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Abstract 
Understanding the structures and interactions of proteins that interact with membranes 
has many implications. Membrane proteins play roles in the transfer of necessary 
materials and information between cells and their environments as well as within cells 
(e.g., between the cytosol and organelles). As such, they currently constitute more than 
half of all drug targets, and some peptides, such as antimicrobial peptides (AMPs), are 
also being investigated for their therapeutic use in treating bacterial infections for humans. 
However, studying the structures of membrane proteins has proven more challenging 
compared to soluble proteins. This is due to the necessity of including the membrane or a 
good membrane mimic to ensure the integrity of the membrane protein remains intact, as 
poor mimics or no membrane can detrimentally affect membrane protein structure and 
function. Some proteins, like the AMP chionodracine, are highly amenable to study with 
methods such as solution NMR spectroscopy (Chapter 2), but larger membrane proteins 
prove challenging or impossible to measure in solution due to the molecular weight 
limitations and frequently do not crystallize easily either. Solid-state NMR spectroscopy 
(ssNMR) has helped to overcome these obstacles and more methodology continues to be 
developed expanding the application of ssNMR. For example, Chapters 3 and 4 of this 
thesis describe new ssNMR methods using the sarco(endo)plasmic reticulum (SERCA) 
and sarcolipin (SLN), respectively. SERCA and SLN form a crucial complex in the 
membrane of the sarcoplasmic reticulum in skeletal muscles cells. Muscle relaxation is 
largely controlled by SERCA pumping calcium out of the cytosol using energy from ATP 
hydrolysis, and SLN inhibits SERCA as well as uncouples the ATP hydrolysis and calcium 
transport. SLN’s effect on SERCA leads to more heat production, which may be important 
to thermogenesis in mammals as well as an additional mechanism to control energy 
expenditure. Chapter 5 primarily uses ssNMR with the goal to better understand the 
mechanism by which SLN inhibits and uncouples SERCA. Overall, gaining a better 
understanding of how SERCA is regulated will aid in developing therapies for diseases 
resulting from improper calcium cycling. 
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Chapter 1 – Introduction 
 Biophysical Characterization of Interactions Between Two Membrane 
Proteins: SERCA and Sarcolipin 
  
  2 
1. Introduction 
1.1 Membrane Proteins 
Determining the structure and dynamics of proteins to understand their 
corresponding functions has been a hallmark of biochemistry,1-3 especially as these 
studies aid the rational design of therapeutics. Membrane proteins are particularly 
important to human health. They constitute 20-30% of the proteins in all genomes4-6 and 
have critical roles in mediating both the transfer of material, such as lipids, sugars, and 
metals, as well as the transfer of information across the membranes of cells. Significantly, 
membrane proteins currently comprise more than half of all drug targets.7-10  However, 
despite their importance to drug development, membrane proteins are still 
underrepresented in the Protein Data Bank (PDB).11,12 More and more membrane protein 
structures are being solved with new method developments, but they still lag behind 
structures solved for globular proteins,13-15 as currently membrane proteins comprise only 
~2% of the protein structures deposited in the data bank.14,16  
In addition to being drug targets, protein-based therapeutics are emerging as a 
new strategy to treat a variety of diseases including cancers,17 chronic inflammatory 
conditions, and other diseases.18 Many of these therapies are based on antibodies,18 but 
peptide therapeutics are also being  developed with the main focus on treating cancers 
and metabolic diseases,19,20 and many of these peptides interact with biological 
membranes. For example, naturally-occurring peptide hormones and antimicrobial 
peptides (AMPs) interact with biological membranes.13,21-23 AMPs, which interact directly 
with some cell membranes, have recently gained considerable attention as potential 
antibiotics,24-26 especially as bacteria are rapidly becoming resistant to conventional 
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treatments.26,27 Further structural characterization of membrane proteins to understand 
their functions as well as their interactions with other proteins and molecules is imperative 
to human health as they are both important drug targets and potential therapeutics. 
 An essential consideration when studying membrane proteins is the membrane 
bilayer and its composition, as these are highly influential in driving membrane protein 
structure and function. The current understanding of the biological membrane is based on 
the fluid-mosaic model first introduced by Singer and Nicholson in 197228 (Fig. 1A).29 
Membranes are necessary for creating boundaries to the outside environment for the cell 
and for organelles within cells. The amphipathic nature of lipids causes them to 
spontaneously form a bilayer in aqueous solution with the hydrophilic heads exposed to 
the water and the hydrophobic tails facing each other.28,30 Membrane proteins are either 
embedded within the membrane (integral membrane proteins) or interact with the polar 
headgroups of the lipids (peripheral membrane proteins). A key component of the model 
is that both the lipids and proteins can diffuse freely,28,31,32 but they are distributed 
asymmetrically among the two monolayers of the membrane.28,33 Since this model was 
introduced, studies have demonstrated that the membrane is more complex.29 It actually 
has a high density of transmembrane proteins (Fig. 1B)29 and some only bind to the 
membrane periodically.34,35 Many membranes are also curved, can exist in different 
phases, and can be laterally heterogeneous or patchy.29,35 Thus, membranes are variable, 
complex, and dynamic, which makes them much more than passive walls.29,35  
Importantly, the diversity of the membrane, including the composition and phase, 
impacts the activity of membrane proteins,36 and all of these aspects are dependent upon 
the type(s) of lipid(s) present in the membrane and interacting with the protein.35 For 
example, the bilayer thickness is controlled by length of the acyl chain of the lipid. If there 
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is a mismatch between the hydrophobic region of the protein and that of the lipid bilayer, 
either the protein, the lipids, or both must deform such that the hydrophobic regions are 
not exposed to the aqueous solution.36 While many studies indicate that the lipids adjust 
around the protein,36,37 helices in transmembrane proteins may also tilt or flex to ensure 
that the hydrophobic areas stay within the hydrophobic core of the bilayer.38-41 It has even 
been proposed that the tertiary structure and function of membrane proteins may be 
regulated by the bilayer thickness.38 Likewise, membrane curvature is affected by the 
types of lipids and has been demonstrated to affect the secondary structure of membrane 
proteins such as AMPs.36,42 Besides the acyl chain, the lipid head group can also alter the 
activity of membrane proteins;43,44 changes in the charge can disrupt the association of 
proteins such as AMPs with the membrane when their association depends on 
electrostatic interactions.42,45 Even specific lipid molecules are important as some 
membrane proteins require certain lipids to bind to them for their proper function.46 
Accordingly, different lipid types are prevalent for different organisms as well as 
organelles,47 it is clear that the membrane proteins will vary accordingly. All of these 
considerations contribute to the interest of studying membrane proteins, but also the 
challenges in purifying and characterizing them.  
 
1.2 Structural Studies of Membrane Proteins using Nuclear Magnetic 
Resonance Spectroscopy 
 Historically, protein structure determination has focused on X-ray crystallography 
and solution nuclear magnetic resonance (NMR) spectroscopy. However, the necessity of 
studying membrane proteins within a lipid bilayer or mimic has hindered structural 
determination, especially for membrane proteins that need lipid bilayers to maintain their 
  5 
structural integrity.15,48 This has been the major factor contributing to the relatively few 
solved structures for membrane proteins compared to globular proteins.13-15 Advances in 
crystallography using new techniques to include lipids49-51 have helped to determine more 
membrane protein crystal structures, but frequently these crystals provide data with low 
resolution.52-54 On the other hand, solution NMR is limited by the size of the molecules 
studied; as the size increases, the tumbling slows and anisotropic interactions begin to 
broaden lines and complicate the spectra.13 While solution NMR remains useful for 
studying small membrane proteins like peptides, solid-state NMR (ssNMR) has been 
revolutionary for membrane proteins. Not only can samples be prepared using large 
proteins and hydrated lipid bilayers,55 but ssNMR has also developed two main methods, 
oriented ssNMR (O-ssNMR) and magic angle spinning (MAS) NMR, to deal with the 
anisotropy inherent in large systems such as membrane proteins reconstituted in lipid 
environments.  
 Chapter 2 of this thesis utilizes solution NMR to investigate the structure of the 
AMP chionodracine (Cnd), and so a brief description of solution NMR for membrane 
proteins is included here. The remaining chapters focus on using ssNMR to understand 
the structure and interactions of the membrane proteins sarcolipin (SLN) and a 
Ca2+ATPase (SERCA), thus, the theory of ssNMR is described in greater detail.  
 
1.2.1 Solution NMR Spectroscopy 
In solution NMR, rapid molecular reorientation averages the anisotropic 
interactions of nuclei with the magnetic field to their isotropic values providing highly 
resolved spectra. Methodological developments have expanded the size limit for solution 
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NMR, but most of the structures solved are still of proteins below 35 kDa in molecular 
weight.13 For membrane proteins, the membrane mimetic contributes to the overall 
molecular weight restricting the resolvable size of the protein even further.56 As such, 
solution NMR is most useful for smaller transmembrane peptides or peptides that interact 
with lipid bilayers as these are more amenable to studies with detergents than large 
membrane proteins. Although the conventional methods for structural determination in 
solution NMR can be used for membrane peptides and proteins, special considerations 
must be considered when preparing these samples. As size limitations inhibit studying 
peptides in lipid vesicles, small membrane-mimetic systems such as micelles or isotropic 
bicelles are employed (Fig. 2),13 but the types of detergents and/or lipids used also need 
to be considered as these can alter the structures of peptides. For example, sodium 
dodecyl sulfate has been shown to induce secondary structure characteristics that are not 
seen with other systems and may not be physiologically accurate.13,57 Generally, having 
the hydrophobic diameter of the micelles match the hydrophobic thickness of the 
membrane protein aids in obtaining high-quality spectra.58  
Furthermore, the conventional experiments in solution NMR establish the structure 
of the peptide, but they do not reveal information about the localization or orientation of 
the peptide relative to the membrane-mimetic system.13 Thus, one more difference 
between solving structures of globular proteins compared to membrane proteins is the 
necessity to use experiments to ascertain this additional structural dimension. Common 
solution NMR experiments adapted for this purpose include nuclear Overhauser effect 
(NOE) measurements between the peptide and detergent,13,59 residual dipole 
couplings,13,60 and/or paramagnetic relaxation enhancements13,61. Overall, solution NMR 
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has significantly aided in the structural determination of peptides such as Cnd, but its use 
is limited for larger systems.   
 
1.2.2 Oriented Solid-State NMR Spectroscopy 
  Between MAS and O-ssNMR, the two main methods for dealing with the 
anisotropic interactions in ssNMR samples, O-ssNMR takes advantage of the orientation-
dependent interactions present to provide structural and topological information about the 
protein, which must be determined to fully describe the structure of a protein within the 
membrane. For example, α-helices may be described by their tilt, rotation, and immersion 
depth within the membrane (see Fig. 3) as well as the solvent exposure of specific 
residues.62 O-ssNMR experiments may be used to obtain most of this information, but 
while high-quality, well-resolved spectra are needed, their quality and resolution depend 
upon the sample being well aligned relative to the magnetic field. Proper alignment 
requires special sample conditions, and it can be very challenging to prepare samples that 
produce high-quality spectra. Currently, there are several methods used to align proteins 
within lipid bilayers in a strong magnetic field. Originally, mechanical alignment was used 
in which lipid bilayers with the protein are stacked between thin glass slides.54 The current 
commonly used method relies on bilayered mixed micelles or “bicelles”63 (Fig. 2). This is 
the method that will be discussed in detail here as the optimization of the bicelle 
preparation protocol led to successful collection of most of the data in Chapters 4 and 5 
of this thesis. 
Bicelles are a mixture of at least two lipids; a long chain lipid (e.g. 
dimyristoylphosphatidylcholine, DMPC) that forms the bilayer and a short chain lipid (e.g. 
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dihexanoylphosphatidylcholine, DHPC) that covers the rim of the bilayer.54,63 In order to 
form a bicelle that aligns with the magnetic field, an important factor to consider is the 
molar ratio between the long and short chain lipids (q): 
q = [long chain]/[short chain] 
When lipids are mixed at certain ratios (q), bicelles in a liquid crystalline phase will form, 
and when they are placed in a strong magnetic field, the intrinsic magnetic susceptibility 
of the phospholipids that constitute the bicelle will cause their spontaneous alignment. 
This occurs such that the membrane normal, or the plane perpendicular to the surface of 
the bilayer, aligns perpendicularly to the external magnetic field.64,65 Additionally, bicelles 
can be “flipped.” When lanthanide ions are added, the sign of the anisotropy for the lipids’ 
magnetic susceptibility is reversed causing the membrane normal to be parallel with the 
external magnetic field.66,67 The bicelle system has several advantages over the 
mechanically-aligned bilayers: 1) normal glass tubes can be used allowing the samples to 
be placed in a round solenoid coil, which is better for signal detection/sensitivity than the 
rectangular scroll coil needed for glass plate samples,54,68 2) hydration can be controlled 
more finely, and 3) these samples have a larger filling factor (i.e., the fraction of the coil’s 
sensitive volume that is filled with sample).54 However, the down side is that bicelles are 
more restrictive than mechanically-aligned samples in the types of lipids that can be used.  
  Proper alignment of bicelles is imperative to collecting high-quality spectra from 
these samples. If the sample is not aligned well relative to the magnetic field, then all 
orientations of the molecules in question will be present in the sample resulting in a 
“powder pattern” (see Fig. 4). For example, the chemical shift anisotropy of the nucleus is 
an orientation-dependent nuclear spin interaction. It can be described by the equation:69 
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ωCS=-ω0 σiso -1/2 ω0 Δ [3cos2θ-1 + ηsin2 θ cos2Ф] 
Where ωCS is the chemical shift, ω0 is the Larmor frequency, -ω0σiso is the isotropic 
frequency, and θ and Ф are the angles as described by Figure 4. The symmetry of the 
chemical shift anisotropy is described by η while Δ describes the span (see Fig. 4). Both 
of these are dependent on the type of nucleus. When all possible orientations of the 
nucleus (e.g., the entire range of angles, θ and Ф) are present, then all possible chemical 
shifts will be observed resulting in the powder pattern. Conversely, when the molecules 
within the sample are uniformly aligned and only one set of angles are present then each 
nucleus will only give rise to one peak in the NMR spectrum, and the position of this peak 
will depend on the nucleus’ orientation.  
  Separated local field experiments utilize this orientation dependence and separate 
the chemical shift from the local field. For example, in the PISEMA experiment 
(Polarization Inversion with Spin Exchange at the Magic Angle), chemical shifts are 
correlated to dipolar couplings.70 Typically, this is the chemical shift of 15N-labeled amides 
with the dipolar coupling between the amide 15N and the bonded 1H. Like the chemical 
shift anisotropy described above, the dipolar coupling is also orientation-dependent, but it 
is given by a different equation:  
ωDC= ωmax (3cos2θ-1)/2 
Where ωDC is the dipolar coupling, ωmax is the maximum dipolar coupling between the 15N 
and 1H nucleus, and θ is the angle of the amide 15N - 1H bond relative to the external 
magnetic field.   
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  In the case of helices, the resulting spectra have a very specific pattern. First, as 
each amino acid has only one amide bond, each peak in the spectra represents one 
residue. (There may be additional peaks for nitrogen-containing side chains, but these will 
be distinct from the backbone). As transmembrane helices have 3.6 residues per helical 
turn, they give rise to a Polarity Indexed Slant Angle (PISA) wheel in PISEMA spectra with 
3.6 peaks per turn of the PISA wheel. Thus, the spectra can be understood as a projection 
of the peptide’s helical wheel.13  
  The PISA wheel provides important topological information as its shape, size, and 
position are directly related to the angle between the helical axis (τ) as well as the rotation 
angle (ρ) and the dynamics of the protein (Fig. 5). For example, as the tilt of the helix 
increases relative to the bilayer normal, the span of 15N-1H dipolar couplings in the PISA 
wheel becomes larger (Fig. 5). The rotation about the helical axis can be determined with 
only a single resonance assignment within the distribution of peaks in the PISA wheel.13 
However, PISEMA on its own does not provide information about the immersion depth of 
the protein within the bilayer or its solvent exposure, which are necessary for fully 
characterizing the structure. PRE measurements can be used for determining immersion 
depth.62 In Chapter 4 of this thesis, the development of a water-edited version of PISEMA 
that enables probing the solvent exposure of the protein is described.71 Overall, the various 
types of experiments that can be performed using the O-ssNMR approach provide 
important, detailed information about the topology of a protein in the bilayer and can be 
used to monitor even small changes in structure such as alterations of tilt angles.58,72-74    
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1.2.3 Magic Angle Spinning Solid-State NMR Spectroscopy 
 MAS ssNMR and O-ssNMR are complementary techniques and each one provides 
important information for understanding a protein’s conformation and dynamics. Unlike 
other methods, such as X-ray crystallography and solution NMR, MAS ssNMR is not as 
limited by sample preparations based on size limitations.75 In fact, the lipid vesicles (Fig. 
2) typically used in ssNMR samples have correlation times in the µs range76 and under 
these conditions, the dipolar couplings and chemical shifts are orientation dependent. Just 
like O-ssNMR, if nothing was done to compensate for the slow tumbling, the spectra would 
show a powder pattern due to the range of angles of the nuclei’s orientation that would be 
present in the sample. However, in MAS ssNMR, these anisotropic interactions are 
averaged out by spinning the sample around an axis at what has been termed the “magic 
angle” (54.7°) with respect to the magnetic field. At this angle, the 3cos2θ-1 term equals 
zero (see equations above), so if the spinning rate is greater than or equal to the 
magnitude of the anisotropic interaction, it will average to zero. Thus, MAS ssNMR can be 
used to obtain high-resolution spectra of membrane proteins similar to solution NMR, 
which includes chemical shift assignments, torsional and distance restraints, and internal 
dynamics.77,78 Together, MAS and O-ssNMR aid in determining a more comprehensive 
view of the structure for the protein being studied. 
 
1.3 Chionodracine- Antimicrobial Peptide 
AMPs are a fascinating class of peptides. They have been found in nearly all 
organisms and display an extraordinary structural and functional variety.79 In addition to 
being antimicrobial, some AMPs can even regulate the immune response.80 As such, it is 
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no surprise that extensive effort has been spent structurally characterizing AMPs. They 
consist of 10-50 amino acids81,82 with greater than 30% of the residues being hydrophobic, 
but with an overall positive charge from +2 to +9.81 The secondary structures of AMPs are 
usually classified into three groups: α-helical, β-sheet, or peptides with extended/random 
coil structure.83-85 The α-helical peptides are commonly unstructured in solution and only 
adopt secondary structure upon interaction with a biological membrane.85,86 There are 
several examples of this type of AMP within the piscidin family.87-90 Their exact mechanism 
of action is still unclear, but it is generally thought that either they disrupt the physical 
integrity of the microbial membrane and/or they cross the membrane to act on intracellular 
targets.81,87 This disruption of the membrane is largely driven by electrostatic forces 
between the negatively-charged bacterial surface and the cationic AMPs.79,81,91 
Chionodracine (Cnd) is a piscidin-like AMP from the Antarctic icefish, Chionodraco 
hamatus,92 and in Chapter 2 of this thesis, its characterization using solution NMR and 
other techniques is described. 
 
1.4 SERCA and SLN- Integral Membrane Proteins 
One important system to structurally characterize is the sarco(endo)plasmic 
reticulum Ca2+-ATPase (SERCA), and its regulators like sarcolipin (SLN). SERCA is a key 
component of calcium signaling, which is of crucial importance to cells as intracellular 
calcium (Ca2+) levels impact a variety of cellular processes including autophagy, 
apoptosis, gene expression, cell cycle control, and cell motility.93-95 SERCA resides in the 
membrane of the endoplasmic reticulum (ER) and sarcoplasmic reticulum (SR) and 
pumps Ca2+ into the organelles’ lumen to maintain cytosolic Ca2+ levels. It is even capable 
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of establishing a Ca2+ concentration gradient of greater than 104- fold across the 
membrane.96 The energy for this feat comes from the hydrolysis of ATP. Further 
underscoring its importance, SERCA is highly conserved and present among all living 
organisms.97 In vertebrates, several isoforms of SERCA are expressed depending on the 
tissue,97 and defects in them can lead to distinctive diseases such as Darier’s disease and 
Brody’s disease, which affect the skin and skeletal muscle, respectively.98 
In muscle cells, Ca2+ cycling also controls contraction and relaxation. 
Depolarization of the sarcolemma activates the dihydropyridine receptor, a voltage-gated 
ion channel, to transport Ca2+ across the sarcolemma into the sarcoplasm. This causes 
the ryanodine receptor (Ryr) to open and release Ca2+ from the SR. The distinct rise in 
cytosolic Ca2+ concentration then leads to muscle contraction through the thick and thin 
filaments. Relaxation is induced mainly through SERCA removing the Ca2+ from the 
sarcoplasm and pumping it into the SR lumen using energy from hydrolyzing ATP (Fig. 
6). However, the amount of Ca2+ SERCA removes varies with the isoforms. SERCA1a is 
expressed in fast-twitch skeletal muscle,99,100 and removes 99% of the Ca2+ from the 
sarcoplasm after muscle contraction whereas SERCA2a is expressed in cardiac and slow-
twitch skeletal muscle101,102 and removes 70% of the total calcium in cardiac muscle.103 
SERCA’s activity must be carefully controlled to prevent Ca2+ mishandling, which can be 
highly detrimental and lead to disease.  
SERCA is regulated by interactions with peptides encoded by small open reading 
frames (smORFs). Until recently, the only known peptides were sarcolipin (SLN) and 
phospholamban (PLN), but in the last few years, more regulators of SERCA have been 
identified including myoregulin,104 DWORF,105 the sarcolambans in Drosophila,106 as well 
as others.107,108 Abnormal expression and mutations of SLN and PLN, respectively, can 
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lead to pathological conditions in humans.109-114 Clearly, it is highly important to understand 
how these peptides interact with and regulate SERCA. 
 SLN is a 31 amino acid transmembrane peptide115,116 that inhibits SERCA1a in 
skeletal muscle and SERCA2a in the cardiac muscle of the atria.109,117,118 The interaction 
of SLN with SERCA decreases the rate of Ca2+-dependent ATP hydrolysis and Ca2+-
dependent Ca2+ transport in vivo and in reconstituted systems.119,120 SLN also uncouples 
Ca2+ transport and ATP hydrolysis in SERCA leading to increased heat production.121-123 
Inhibition by SLN can be reversed through phosphorylation at Thr-5 of SLN, and though 
the physiological role for phosphorylation of SLN is still unclear, there is evidence that 
preventing phosphorylation in cardiac muscle is detrimental.124-126 Although no mutations 
of SLN have yet been associated with disease, the SLN and SERCA1a complex has 
recently received attention for its importance to metabolism and thermogenesis. In mouse 
skeletal muscle, SLN and SERCA1a have a profound effect on heat generation via non-
shivering thermogenesis.123,127 In fact, SLN-knockout mice were unable to maintain their 
core body temperatures at 4 °C and became susceptible to cold-induced hypothermia, 
irrespective of the presence or absence of their intrascapular brown adipose tissue.104 
These mice were also fed a high fat diet; those expressing SLN were able to compensate 
for the metabolic overload suggesting that the interaction between SERCA and SLN has 
a key role in metabolism and obesity.104 Despite what is known about their functions, the 
interactions between SLN and SERCA and how they lead to inhibition and thermogenesis 
is not well understood.  
 Countless structural studies have contributed to our general understanding of 
integral membrane protein structure as well as the independent structures of SLN and 
SERCA. These studies have shown that membrane protein structures can be more 
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complex than originally considered. For example, helical membrane proteins were initially 
thought to be long, hydrophobic α-helices whose orientation was essentially perpendicular 
to the membrane plane.12,128 It is now accepted that hydrophobic α-helices can cross the 
membrane at a variety of angles, have kinks, be interrupted in the middle of the 
membrane, and even cross only part of the membrane and turn back.12 However, there 
are known factors that govern these structures. The residues in the middle of the 
membrane tend to be hydrophobic amino acids whereas the aromatic residues tyrosine 
and tryptophan are found near the lipid-water interface.12,129 If the length of this 
hydrophobic region does not match the hydrophobic thickness of the bilayer, (referred to 
as hydrophobic mismatch), the helix may tilt or flex ensuring the hydrophobic region is not 
exposed to a hydrophilic environment,38-41 but the rotation angle of the helix is likely 
unaffected.130 However, the lipids adjusting around the protein may be the more common 
mechanism to compensate for hydrophobic mismatch.36,37 Compared to helices in globular 
proteins, there is a higher proportion of glycines and prolines in membrane protein 
helices,131,132 which along with serine, threonine, asparagine, and glutamine, can cause 
kinks in the helix.133-135 Although charged and polar residues are mostly absent from the 
membrane region, the frequency with which positively-charged residues are found on the 
cytoplasmic side compared to the non-cytoplasmic side has led to this being termed the 
“positive-inside rule.”12,136,137 Beyond individual helices, a simplified view of the packing of 
adjacent helices is that their side chains fit into a knobs-into-holes geometry.138-140 Overall, 
membrane protein structure is becoming less mysterious, but there is still much more to 
be learned.  
The individual structures of SLN and SERCA have both been well studied. SLN’s 
structure was first solved in SDS micelles, which found that SLN is helical from residues 
  16 
9-27 and that the N-terminus is more disordered than the C-terminus.141 Determination of 
the structure in dodecylphosphocholine (DPC) micelles revealed a nearly identical 
structure to the one in SDS though residues 6-27 were helical.142 The study in DPC 
micelles also investigated the structural dynamics of SLN and divided it into four parts: two 
highly mobile termini (residues 1-6 and 27-31) and two dynamically distinct segments of 
the α-helix with the more hydrophilic residues (7-14, domain Ib) being less rigid than the 
more hydrophobic region (15-26, domain II) (Fig. 7A).142 Importantly, SLN has also been 
characterized in several lipid environments. Glass plate samples with 4:1 1,2-Dioleoyl-sn-
glycero-3-phosphocholine/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPC/DOPE) showed SLN’s tilt angle to be 23° ± 2°,143 which is very similar to the tilt 
angle of 24° ± 1° determined for SLN in bicelles composed of DMPC/DHPC as well as 
DMPC+POPC/DHPC (POPC is 1-Palmitoyl,2-oleyl-sn-glycero-3-phosphocholine).144,145 
With all of this information, SLN has also been useful for method development,144,146-149 
including that described in Chapter 4 of this thesis.71   
SERCA is one of the most well-studied membrane proteins, thus, a significant 
amount is known about its structure and function. SERCA is 110 kDa with 10 
transmembrane helices (M1-M10) and three cytoplasmic domains: the actuator (A), 
nucleotide-binding (N), and phosphorylation (P) domains (Fig. 7B).150 The coordinated 
movement of these domains allows for the transport of Ca2+ ions from the cytosol to the 
lumen in exchange for two to three protons.151-153 The energy to pump Ca2+ against its 
concentration gradient is derived from the hydrolysis of ATP; SERCA transports two Ca2+ 
ions per ATP hydrolyzed under ideal conditions.154-157 Structural and kinetic studies have 
provided an understanding of the mechanism of transport (Fig. 8). The Ca2+ ions bind to 
two sites within transmembrane helices M4, M5, M6, and M8.150 In Site I, Ca2+ coordinates 
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to the side chains of Glu-771 (M5), Asp-800 (M6) and Glu-908 (M8), and with the 
backbone carbonyl groups from Asp-768 (M5) and Thr-799 (M6). The coordination of Ca2+ 
in Site II is with the carboxyl groups of Glu-309 (M4, bidentate coordination) and Asp-800 
(M6) as well as the backbone carbonyl groups of Val-304 (M4), Ala-305 (M4), Ile-307 (M4), 
and Asp-796 (M6).150 There are two main categories for the structural states of SERCA, 
high Ca2+-affinity, E1 states and low Ca2+-affinity, E2 states.150 The transport cycle begins 
with cytosolic Ca2+ binding to the E2 state causing the release of the bound protons and 
SERCA’s transition to the E1 state.150 Asp-351 in the P-domain is subsequently auto-
phosphorylated by the bound ATP forming the high-energy [2Ca2+]E1~P:ADP state. This 
coincides with conformational changes in the A-domain, which are propagated to the 
transmembrane helices largely through linkers to M1 and M2 and cause the Ca2+ ions to 
become occluded. SERCA then transitions to the [2Ca2+]E2-P:ATP state where the ADP 
is exchanged for ATP. The Ca2+ ions are de-occluded and released into the SR lumen and 
protons bind in exchange for these Ca2+ ions (HnE2P:ATP). Dephosphorylation then 
occurs forming the HnE2:ATP state and allowing SERCA to re-start the transport cycle.  
Despite the volume of information known about SLN and SERCA, how their 
interactions lead to the inhibition and uncoupling of SERCA is not well understood. 
Mutagenesis studies have demonstrated that several residues within the transmembrane 
region of SLN can affect SERCA’s maximal activity as well as its apparent calcium affinity, 
which have established that the transmembrane region of SLN is involved in the regulation 
of SERCA.119 Recently, two X-ray structures of SLN bound to SERCA have shed more 
light on the interactions of the transmembrane region of SLN with SERCA and confirmed 
previous cross-linking and mutational studies placing SLN within helices M2, M4, M6, and 
M9 of SERCA.123,158-160 And although neither study fully revealed the mechanism of 
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regulation, both studies were important steps in understanding the complex and provided 
useful information to consider for future models. Winther et al. compared the binding site 
of SLN observed in their crystal structure to the [Hn]E2 and [2Ca2+]E1P structures.159 As 
the groove where SLN binds narrows significantly from the [Hn]E2 to the [2Ca2+]E1P 
states, the authors found it likely that SLN will be displaced or repositioned when SERCA 
shifts between these conformations,159 though cross-linking studies suggest that SLN is 
repositioned upon Ca2+ binding rather than being dissociated from SERCA.123 Toyoshima 
et al., on the other hand, concluded that SLN’s position stabilizes an E1·Mg2+ state, 
between E2 and E1, interfering with SERCA’s transition into the [2Ca2+]E1 state as the 
movement of M2 will be suppressed.158 Additionally, the authors noted that SLN causes 
the A domain to undergo a larger rotation when moving into the [2Ca2+]E1 state, providing 
an explanation for SLN’s inhibitory kinetic effects.158 There are caveats to these findings 
as both of these structures were crystallized under concentrations of Mg2+ significantly 
higher than physiological levels, and even though these structures were crystallized under 
similar conditions (i.e., high Mg2+ and AMPPCP present), there are differences in the 
arrangement of cytoplasmic domains (the arrangement of the transmembrane helices is 
very similar between the two).158,159,161 Thus, the role of the transmembrane region of SLN 
in regulating SERCA is not fully understood. 
Although the transmembrane domain is critical for SLN’s interaction with SERCA, 
SLN’s termini also seem to play a crucial role in causing inhibition.120 The C-terminus 
(referred to as the luminal tail from here on) of SLN had previously been found to be vital 
for proper SR retention.162 While the luminal tail is highly conserved, especially among 
mammals, the N-terminus is quite variable, a difference that implies a role beyond 
retention.120 In fact, individual mutations of each residue of the luminal tail to alanine result 
  19 
in decreased inhibitory activity, and removing the luminal tail entirely results in a major 
loss of function.120 It also seems that SLN’s luminal tail is more important than its 
transmembrane region for inhibition, which is in contrast to PLN.120 The luminal tail is 
thought to interact with the luminal end of the M2 transmembrane segment of 
SERCA,120,160,163 and the M1-M2 region of SERCA is known to undergo large structural 
rearrangements when the enzyme transitions from the calcium-free E2 state to the 
calcium-bound E1 state.150 Unfortunately, neither crystal structure of the SLN-SERCA 
complex shows the luminal tail clearly,158,159 but there is evidence from ssNMR that the 
tyrosines of the luminal tail do interact with SERCA1a.163 As such, it seems likely that 
SLN’s molecular interactions with the M1-M2 region of SERCA lead to inhibition. 
Compared to the luminal tail, less is known about SLN’s N-terminus. A recent study 
suggested that the N-terminus causes the uncoupling of Ca2+ transport and ATP 
hydrolysis in SERCA,164 and corresponding molecular dynamics simulations indicated that 
this could be through the N-terminus’ interactions with the cytosolic part of SERCA’s M4 
helix,164,165 which is part of the energy transduction domain critical for coupling transport 
and hydrolysis.165-170 Overall, these studies suggest that each domain of SLN contributes 
to its regulation of SERCA, but it is still unclear how much each domain contributes to 
inhibition versus uncoupling of SERCA. 
Studying membrane protein structure was the central focus of the work described 
in this thesis. Preparing the NMR sample of Cnd in DPC micelles as described in Chapter 
2 and running the initial NMR experiments taught me about how to work with membrane 
peptides and contributed to my understanding about how peptides interact with biological 
membranes. This knowledge was applied to optimizing the bicelle samples for SLN, which 
led to the work presented in Chapter 4 as the increased sensitivity and resolution of my 
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samples allowed for the development of the WESE-PISEMA experiment. Synthesizing 
and testing the ethylating reagent used to modify SERCA (Chapter 3), and ultimately 
seeing the final data regarding SERCA’s cytoplasmic domains, further honed my approach 
to thinking about the SLN+SERCA complex. Together, the expertise I acquired from these 
studies was instrumental to further optimizing ssNMR samples of the SLN+SERCA 
complex to help discover how the transport cycle of SERCA is modified by regulators such 
as SLN. For example, does SLN’s topology change during SERCA’s transport cycle? And 
how do these molecular interactions lead to uncoupling in SERCA? What is the effect of 
phosphorylation? The data presented in Chapter 5 help to address these outstanding 
questions. 
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Figure 1. A) The Singer–Nicholson 'fluid mosaic model'.28 B) An amended and updated 
version.  
 
Reprinted by permission from Macmillan Publishers Ltd: Nature. (Engelman, D.M. 
Membranes are more mosaic than fluid), copyright (2005).29  
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Figure 2. Membrane mimetics for solution NMR and the main solid-state NMR 
spectroscopy methods (O-ssNMR and MAS). 
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Figure 3. An α-helix in a lipid membrane showing the tilt angle (τ), rotation angle (ρ), 
hydrophobic thickness (D), and the shift (d) along the membrane normal (Z). The shift is 
related to the immersion depth of the helix within the membrane. Adapted from OPM 
database.171 
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Figure 4. A) The static NMR signal is dependent on Δ and η. B) The principal components 
of the chemical shift tensor (σxx, σyy, and σzz) with the electron field surrounding the nucleus 
represented by the black ellipse. From: Chem LibreTexts.69 
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Figure 5. The PISA wheel is dependent on τ for an α-helix in flipped (top) and unflipped 
(bottom) bicelle samples.  
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Figure 6. Schematic of a myocyte. The SR forms a network around the myofibrils, which 
are composed of the myofilaments. 
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Figure 7. A) The structure of SLN with the different dynamic domains delineated.  B) X-
ray structure of SERCA with SLN (orange) bound to the transmembrane domain (gray).  
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Figure 8. Schematic of SERCA’s transport cycle. Adapted from Moller et al.150   
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Chapter 2 - Structure and membrane interactions of chionodracine, a 
piscidin-like antimicrobial peptide from the icefish 
Chionodraco hamatus 
 
 
Reprinted and adapted from:   
Biochim Biophys Acta, 1848(6), Cristina Olivieri, Francesco Buonocore, Simona 
Picchietti, Anna Rita Taddei, Chiara Bernini, Giuseppe Scapigliati, Alysha A. Dicke, 
Vitaly V. Vostrikov, Gianluigi Veglia and Fernando Porcelli. Structure and 
membrane interactions of chionodracine, a piscidin-like antimicrobial peptide from 
the icefish Chionodraco hamatus, 1285-93, Copyright (2015), with permission from 
Elsevier. 
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Abstract 
Chionodracine (Cnd) is a 22-residue peptide of the piscidin family expressed in the gills of 
the Chionodraco hamatus as protection from bacterial infections. Here, we report the 
effects of synthetic Cnd on both Psychrobacter sp. TAD1 and Escherichia coli bacteria, 
as well as membrane models. We found that Cnd perforates the inner and outer 
membranes of Psychrobacter sp. TAD1, making discrete pores that cause the cellular 
content to leak out. Membrane disruption studies using intrinsic and extrinsic fluorescence 
spectroscopy revealed that Cnd behaves similarly to other piscidins, with comparable 
membrane partition coefficients. Membrane accessibility assays and structural studies 
using NMR in detergent micelles show that Cnd adopts a canonical topology of 
antimicrobial helical peptides, with the hydrophobic face toward the lipid environment and 
the hydrophilic face toward the bulk solvent. The analysis of Cnd free energy of binding to 
vesicles with different lipid contents indicates a preference for charged phospholipids and 
a more marked binding to native E. coli extracts. Taken with previous studies on piscidin-
like peptides, we conclude that Cnd first adsorbs to the membrane, and then forms pores 
together with membrane fragmentation. Since Cnd has only marginal hemolytic activity, it 
constitutes a good template for developing new antimicrobial agents. 
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2.1 Introduction 
Antimicrobial peptides (AMPs) represent an ancestral eukaryotic mechanism of 
immunity against prokaryotic organisms.172-174 In particular, fish express a large variety of 
antimicrobial peptides, such as defensins, cathelicidins, hepcidins and piscidins.92,175,176 
Fish AMPs such as piscidin-2 act as anti-infective agents, and display high potency 
against human and fish pathogens,177 while other peptides, such as epinecidin-1, show 
anticancer activity against human fibrosarcoma cells.20 
Among the fish AMPs, piscidins constitute a rather interesting family. They are 
histidine- and phenylalanine-rich peptides with a broad spectrum of antimicrobial activity, 
and are effective against viruses, fungi and bacteria.177 Three isoforms of piscidin have 
been isolated from the fish mast cells (i.e., piscidins 1, 2, and 3), differing by one or two 
residues.178 Also, a new type of piscidin (i.e., piscidin-4) comprising 44 residues has been 
isolated and characterized from hybrid striped bass.179 Interestingly, piscidins display in 
vitro anti-tumor activity against various cancer cell lines, such as HL60, HeLa180, MCF7, 
and 4T1.181 While the activity of piscidins has been attributed to their ability to form pores 
and disrupt cell membranes, they also have immunomodulatory properties, suggesting 
that they may target specific receptors.182,183 Other reports show that piscidins may also 
inhibit the biosynthesis of the cell wall, nucleic acids, and proteins, or alternatively, inhibit 
the pathogens' enzymatic activity.175 
We recently discovered a new antimicrobial peptide of the piscidin family named 
chionodracine (Cnd), which is produced by Chionodraco hamatus, an Antarctic teleost 
icefish, of the Channichthyidae family.92 Cnd protects Chionodraco from infections; 
specifically, from the attack of Psychrobacter sp. TAD1 and TA144, two psychrotolerant 
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and psychrophilic bacteria strains typical of the Antarctic marine and terrestrial 
environments.92 Cnd is expressed in the gills and head kidney of the Chionodraco as an 
80 amino acid precursor and cleaved into a mature 22-residue peptide 
(FFGHLYRGITSVVKHVHGLLSG). We found that Cnd is active toward 
both Psychrobacter sp. TAD1 and TA144, but also shows activity toward Gram-
positive Bacillus cereus and Gram-negative Escherichia coli. The minimum inhibitory 
concentrations (MIC) of the Cnd against mesophilic and psychrophilic bacteria have been 
previously reported and range between 5.00 and 20 μM.92 Importantly, Cnd does not show 
any significant hemolytic activity toward human erythrocytes, with a ~ 0.8% percentage of 
hemolysis at 50 μM,92 making it a promising template to develop new molecules with 
antimicrobial activity. Cnd's primary sequence is remarkably similar to that of other 
peptides belonging to the piscidin family, sharing the two N-terminal phenylalanines, the 
central glycine, and three histidines (Fig. 1). Although we have described the gene 
sequence, localization as well as the bactericidal activity of Cnd, we had yet to determine 
its interactions with prokaryotic cell membranes as well as the molecular and structural 
features of this peptide in membrane mimetic environments. 
Here, we report the membranolytic properties and structural characterization of 
Cnd using transmission electron microscopy (TEM), cell permeation assays, and NMR 
spectroscopy. We found that Cnd interacts with cell membranes, disrupting the inner and 
outer membranes of both Psychrobacter sp. TAD1 and E. coli bacteria. In particular, TEM 
images reveal that Cnd forms well-defined pores in the bacterial membranes. Moreover, 
experiments carried out with synthetic membranes reveal a small but significant 
preference for negatively charged lipid membranes and a more marked affinity for E. coli 
bacteria membranes. The three-dimensional structure of Cnd is very similar to that of the 
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piscidin-1 peptide, adopting a canonical amphipathic helix, with hydrophobic amino acids 
adsorbed on the membrane surface and the hydrophilic amino acids pointing toward the 
bulk solvent. Taken together, the helical propensity (disorder to order transition), 
membrane binding assays, and TEM images show the formation of discrete pores as well 
as membrane fragmentation that enable the cellular content to leak out and killing the 
cells. 
 
2.1 Materials and Methods 
2.1.1 Peptide synthesis 
The Cnd peptide (> 95%) FFGHLYRGITSVVKHVHGLLSG was purchased from 
United Biosystems Inc., USA. Peptide concentration was determined by light absorption 
at 280 nm before each sample preparation. 
 
2.1.2 Lipid vesicle preparation 
LUVs (Large Unilamellar Vesicles) of the appropriate lipid or lipid mix suspension 
were prepared by extrusion with an Avanti Polar mini-extruder through a polycarbonate 
membrane with pore sizes of 100 nm. Lipid vesicles were composed of 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC), mixtures of POPC and 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphoglyceol (POPG), or E. coli B extract, ATCC 11303, comprised of 
57.5% PE, 15.1% PG, 9.8% cardiolipin (CA), and 17.6% unknown (Avanti Polar Lipids 
Inc.). All the lipid vesicles were prepared as reported in the following sections. 
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2.1.3 Transmission Electron Microscopy (TEM) 
Psychrobacter sp. TAD1 Antarctic bacteria were grown aerobically and cultured at 
15 °C for 48 h in Luria–Bertani broth to mid-log phase (OD600 of 0.35), centrifuged at 
3000 g for 10 min at 25 °C, washed and resuspended into 10 mM Tris–HCl (pH 7.4), and 
150 mM NaCl (working buffer) to a final OD600 of 0.5. Treated cells were incubated with 
Cnd antimicrobial peptide (15 μM, PM 2424.83) while control cells were maintained in 
working buffer, all the groups of cells were then collected at 0, 10 and 180 min and fixed 
with 2% paraformaldehyde + 2.5% glutaraldehyde in cacodylate sucrose buffer (0.1 M 
cacodylate, 0.09 M sucrose, 0.01 M CaCl2, 0.01 M MgCl2, pH 6.9) containing 0.075% 
ruthenium red and 0.075 M lysine acetate for 20 min at 4 °C. Samples were washed in 
cacodylate sucrose buffer containing 0.075% ruthenium red and then fixed with 2% 
paraformaldehyde + 2.5% glutaraldehyde in cacodylate sucrose buffer containing 0.075% 
ruthenium red overnight at 4 °C. After washings in the cacodylate sucrose buffer 
containing 0.075% ruthenium red, samples were post-fixed in 1% OsO4 + 0.075% 
ruthenium red in 0.1 M cacodylate buffer at pH 7.2 for 1 h at room temperature and then 
washed again in the cacodylate sucrose buffer containing 0.075% ruthenium red. 
Specimens were dehydrated in a graded ethanol series and embedded in LR White resin 
(Multilab Supplies, Surrey, England).184 The resin was polymerised in tightly capped 
gelatine capsules for 48 h at 50 °C. Thin sections were cut with Reichert Ultracut and LKB 
Nova ultramicrotomes using a diamond knife, collected on copper grids, stained with 
uranyl acetate and lead citrate, and observed with a JEOL 1200 EX II electron microscope 
at 100 kV. Micrographs were acquired by the Olympus SIS VELETA CCD camera 
equipped the iTEM software. TEM images (at the same magnification) were analysed to 
determine the percentage of damaged bacteria (bacteria with destroyed membranes) both 
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in controls and treated cells, by counting a total number of 50,000 cells. All the numerical 
results are presented in the text as mean ± SD. Homogeneity of variances was tested 
before data processing. To detail the source of variation attributed to treatment and time 
factors, two-way ANOVA was applied, followed by Bonferroni's test. Data were analysed 
using the GraphPad Prism 3.0 software statistical package. The level for accepted 
statistical significance was P < 0.01. 
 
2.2.4 Steady-state fluorescence experiments 
Partition Studies 
A Perkin Elmer LS55 steady-state fluorescence spectrometer was used for steady-
state fluorescence measurements. The experiments were carried out at 25 °C in a 
thermostated cell holder equipped with magnetic stirrer. In order to correct for polarization 
effects and reduce direct contributions from the vesicles, light scattering measurements 
were carried out with a cross-oriented configuration of polarizers (Polem = 0° 
and Polexc = 90°).185 The partition of Cnd with lipid vesicles was quantified by titrating the 
peptide samples in 20 mM phosphate buffer at pH 7.4 containing EDTA 0.8 mM and NaCl 
150 mM with increasing amounts of vesicle stock solutions; the lipid/peptide ratio ranged 
from 50 to 500. These binding assays were repeated with LUVs of different compositions: 
100% POPC, 70%/30% POPC/POPG, and E. coli B extract. The lipid titrations were 
monitored following the increase of Tyr-6 fluorescence at λem = 320 nm upon excitation 
at λexc = 274. The background signals of both buffer and lipid vesicles were subtracted 
from each spectrum. The partition constant Kx, was defined according to Wimley and 
White:186,187 
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where [P]bil and [P]water are the bulk molar concentration of peptide in the bilayer and in the 
water, and [L] and [W] are the molar concentrations of lipid and water, respectively. The 
partition constants were measured by titrating a 1 μM solution of Cnd with increasing 
amounts of lipid vesicles of varying compositions, then calculating the fraction of the 
peptide, fp, partitioned into the lipid vesicles. Considering that [P]tot = [P]water + [P]bil188,189 
the expression for fp is: 
 
The values of Kx were determined by the plot of fp vs [L] using the GraphPad Prism 6 
software package (GraphPad Software Inc.). Experimental data were fitted using 
equation:188 
 
where F is the fluorescence intensity, Fo and Fmax are the fluorescence intensities before 
lipid vesicle addition and at saturation, respectively. In order to avoid the non-ideal 
behavior occurring at higher concentrations,187,190 the molar partition coefficients were 
evaluated at a low peptide concentration (~ 1 μM). 
 
Outer membrane disruption assay 
For cell permeabilization studies, we used ANS (1-aminonaphtalene-8-sulfonic 
acid) uptake assays191 with E. coli BL21(DE3) and Psychrobacter sp. TDA1 bacteria. 
Bacterial cells were cultured in LB medium. Cells from the mid-log phase were centrifuged, 
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washed, and then resuspended in PBS buffer to achieve an OD600 of ~ 1.2. Increasing 
amounts of peptide (ranging from 1.0 to 15.0 μM) were added to 1.0 mL of cell suspension 
in the presence of 5.0 μM of ANS. The spectra were recorded between 400 and 600 nm 
with an excitation wavelength of 360 nm and excitation/emission band-passes of 5.0 nm. 
The disruption of the outer membrane was quantified by the increase in fluorescence 
intensity and the blue shift of the spectra. 
 
Calcein leakage studies 
The kinetics of calcein release were followed by monitoring the fluorescence 
increase upon peptide binding to vesicles at different lipid compositions. LUVs charged 
with 50 mM calcein were prepared by an extrusion process. Briefly, the appropriate 
amount of lipids was dissolved in chloroform in a small round bottom flask and the solvent 
was gently removed in a rotary evaporator. The remaining solvent was removed under 
vacuum overnight at room temperature. The dried lipid films were hydrated with MOPS 
buffer at pH 7.5 containing 70 mM NaCl, 0.8 mM EDTA, and 50 mM calcein. The lipid 
suspensions were vortexed at room temperature and subjected to 5 freezing and thawing 
cycles. After freezing, the sample was heated to 50 °C and the mixture subjected to 
extrusion cycles using an Avanti polar mini-extruder containing two stacked 100 nm 
polycarbonate filters. To separate the non-encapsulated calcein in the external medium, 
the mixture was passed through a Sephadex-G50 column. Columns containing the 
calcein-loaded vesicles were centrifuged for 3 min at 1000 rpm. The lipid concentration 
was measured via the static light scattering at 90° of the lipid suspension at 550 nm and 
compared with a calibration curve.192 The Bartlett method was used to determine the total 
phospholipid concentration. Fluorescence studies were carried out at 25 °C with an 
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excitation wavelength of 490 nm, producing an emission wavelength of 520 nm. The 
excitation and emission band-passes were 2.5 nm. LUVs charged with 50 mM calcein 
showed very little fluorescence quantum yield due to calcein self-quenching. The increase 
in observed fluorescence was due to the vesicle leakage caused by peptide addition. 
Before peptide titration (from 0.1 to 1.0 μM), the fluorescence baseline was monitored for 
5 min and no deviations were observed. After peptide addition, the fluorescence was 
monitored up to 2000 s. To obtain the maximal leakage of the vesicles and normalize 
fluorescence intensities, we added ~ 5 μL of 0.1% solution of Triton X to each sample. 
Before each measurement, we performed light scattering experiments between 540 and 
560 nm to assess the integrity of the vesicles.192 Fluorescence traces were fitted with a 
double exponential equation:192 
𝐹𝑡 = 𝐹𝑒𝑞 − 𝑎1𝑒
−𝑘1𝑡 − 𝑎2𝑒
−𝑘2𝑡 
where Ft and Feq are the fluorescence at time t and at t → ∞, respectively, the 
constants a1 and a2 represent the fractions of the two kinetic components 
and k1 and k2 are the respective constants expressed in s− 1. The percentage of calcein 
release was calculated using the formula:
 
 
where F is the fluorescence upon addition of peptide, F0 is the initial fluorescence before 
the addition of peptide and Ft is the fluorescence upon addition of Triton-X. 
 
 
0
0(%) 
FF
FF
releaseDye
t 


  39 
Iodide quenching experiments 
Quenching of the tyrosine fluorescence both in the presence and absence of lipid 
vesicles was measured by addition of increasing aliquots of potassium iodide.193 The 
excitation wavelength was set to 274 nm and florescence spectra were recorded between 
295 and 360 nm. Fluorescence spectra were corrected for dilution and for the absorption 
of fluorophores and quenchers. The data were fitted according to the Stern–Volmer 
equation: 
𝐹𝑜
𝐹
= 1 + 𝐾𝑆𝑉[𝑄] 
where Fo and F are the fluorescence in the absence and presence of the quencher Q, 
respectively, and KSV is the Stern–Volmer constant accounting for the collisional 
quenching process.194 
 
NMR sample preparation and spectroscopy 
The lyophilized peptide was dissolved in an aqueous solution (5% 2H2O, 95% H2O) 
containing 300 mM perdeuterated DPC (Cambridge Isotope Laboratories) and 20 mM 
phosphate buffer at pH ~ 6.5 to a final concentration of ~ 1.5 mM. All of the NMR 
experiments were acquired at 300 K on a Varian Inova 900 MHz spectrometer. The 2D 
[1H, 1H] total correlation spectroscopy (TOCSY)195 (50 and 70 ms mixing time) and 2D 
[1H, 1H] NOESY196 (70–300 ms mixing time) experiments were run in the phase-sensitive 
mode using time-proportional phase incrementation (TPPI) for quadrature detection in the 
indirect dimension. All of the pulse sequences utilized a WATERGATE pulse 
scheme197 for solvent suppression. The experiments were acquired with 256 and 1024 
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complex data points in the t1 and t2 dimensions, respectively, with 64 scans per increment. 
The 90° pulse width was 30 kHz, and recycle delay was set to 1 s. A DIPSI-2 pulse 
sequence198 was used for isotropic mixing in the 2D TOCSY experiments. The spectral 
widths were 5400 Hz t1 and 7200 Hz t2 dimensions. The 2D data were zero-filled to 8192 
points in t1 and to 4096 points in t2 and then processed with a sine-bell squared window 
function shifted between 60° and 90° before Fourier transformation. A polynomial function 
was used for baseline correction in the direct frequency dimension. The NMR data were 
processed using NMRPipe199 and analyzed with SPARKY200 software packages. Proton 
dimension was referenced to the water line at 4.7 ppm. The spectra were assigned using 
the standard assignment approach described by Wuthrich.201 [1H,13C] HSQC and HMBC 
spectra were acquired on a Bruker 900 MHz spectrometer at 30 °C. All the 13C 
experiments were carried out at natural abundance. Analysis of the natural abundance 
of 13C edited HSQC and HMBC has been used to resolve amino acid spin system 
assignments as well as provide 13Cα and 13Cβ chemical shifts. A table with all of the 1H 
chemical shift resonances is provided in the supporting information. 
 
Structure calculations from NMR data 
NOE cross-peaks from the 150 and 300 ms mixing time [1H, 1H]-NOESY 
experiments were integrated and used for the structure calculations. The NOE volumes 
were calibrated using the average NOE volume from resolved aromatic vicinal protons of 
Y6 and classified as strong, medium, and weak, corresponding to distance restraints of 
1.8–2.9, 1.8–4.5, and 1.8–5.0 Å, respectively. TALOS + software202 was used to obtain 
the dihedral constraints for residues 3 through 19 that were then implemented in the 
structure calculations. The NMR conformers were calculated starting from an extended 
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conformation of Cnd and minimized using a hybrid simulated annealing (SA) energy 
minimization protocol available in XPLOR-NIH203. A total of 100 conformers were 
generated using random seeds at an initial temperature of 5000 K with 6000 high 
temperature steps, 3000 cooling steps, and a step size of 5 fs. The final target function 
included a total of 240 NOEs (75 intra-residue and 165 inter-residue distances). The final 
stage of refinement of the structural ensemble was carried out starting at an initial 
temperature of 500 K and using 30,000 cooling steps with a 1 fs step size. The 70 refined 
structures had no NOE violations greater than 0.5 Å, no bond violations greater than 
0.05 Å, and no bond angle violations greater than 4°. The 40 lowest energy conformers 
were then selected for further analysis. The analysis of Ramachandran angles for the 40 
lowest energy structures was carried out using Molprobity204. For the final conformers, the 
occurrence of the ϕ and ψ angles for all of the residues in the Ramachandran plots was 
83.6% in the most favored region, 11.1% in the allowed, 1.6% in the generously allowed, 
and 3.7% in disallowed regions. The residues located in the N- and C-termini, which had 
fewer structural restraints, account for those found in the disallowed regions of the 
Ramachandran plots. 
 
2.3 Results 
2.3.1 Effects of Cnd on the inner and outer membranes of Psychrobacter sp. TAD1 
bacteria using transmission electron microscopy (TEM) 
Examination of the Psychrobacter sp. TAD1 by TEM (Fig. 2A) revealed that the 
bacterium is bounded by two membranous structures. These two membranes, the inner 
membrane (IM) and the outer membrane (OM), are separated by a gel-like layer known 
as the periplasm (Fig. 2B). A large number of spherical structures, resembling the outer 
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membrane vesicles (OMVs) of Gram-negative bacteria, were found in the extracellular 
matter, mainly interspersed among cells. A process of bulging out and pinching off of a 
portion of the bacterial OM, which plays a dynamic role in the formation of OMVs, was 
noticed in many cells (Fig. 2A; C). The formation of OMVs is a common feature of cold-
adapted bacteria that utilize these extracellular vesicles for sensing nutrients.205  
Compared to control, treatment of Psychrobacter sp. TAD1 bacteria with the Cnd 
peptide (10–80 min) induced a significant increase (P < 0.01) of the number of cells with 
membrane damage (Fig. 3). 
After 10 min of treatment Cnd perforated both OMs and IMs, with the consequent 
loss of intracellular components (Figs. 2D and E). Interestingly, this process is localized 
in well-defined areas, suggesting the formation of well-defined pores (Fig. 2E). After 
180 min of treatment we observed no further increase of damaged bacteria (Fig. 3). Cnd 
also damaged the cell membranes of dividing cells, with leakage of cellular contents and 
breakup of the basic cellular structure (Fig. 2F). In the extracellular matter were observed 
fragments of destroyed cellular membranes, whose contents were lacking (Fig. 2G). The 
morphology of the cellular damage and the time course of the process suggest that Cnd 
might aggregate on the cell surface, forming well-defined pores together with membrane 
fragmentation. Discrete pores have been observed for the antimicrobial peptide piscidin-
1.175 
 
2.3.2 Outer membrane permeability assay 
To compare the ability of Cnd to damage the integrity of the outer membrane 
of Psychrobacter sp. TDA1 and E. coli bacteria, we used the ANS (1-aminonaphtalene-8-
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sulfonic acid) fluorescence assay.191 Because of its hydrophobic nature, ANS is not able 
to pass the cell wall of either Psychrobacter sp. TAD1 or E. coli, giving rise to a weak 
fluorescence signal caused by the high polarity of water. Upon titration of the bacteria cells 
with Cnd, ANS penetrates the cell membranes, causing a drastic increase of its 
fluorescence accompanied by a blue shift of the band (Fig. 4). This dose-dependent effect 
is notable at concentrations as low as 1 μM for both Psychrobacter sp. and E. coli 
bacteria, confirming our previous data from the antibacterial activity assays.92 
 
2.3.3 Membrane partition of the chionodracine peptide 
To quantify the interaction of Cnd with membrane mimetic systems and assess the 
effects of lipid charges, we measured the fluorescence emission of Tyr-6 of Cnd upon 
partitioning within membranes of different compositions. Figure 5 shows the binding 
isotherms for Cnd upon addition of increasing amount of lipid vesicles. 
The mole fraction partition coefficients Kx obtained from the curves ranging from 
3 × 104 to 2 × 105 are reported in Table 1. The calculated Gibbs free energies of the 
water/bilayer partition are − 25.6 kJ/mol for pure POPC, − 26.5 kJ/mol for the 
POPC/POPG mixture, and − 29.9 kJ/mol for the E. coli lipid extract. From these data, it is 
possible to see a small but significant increase of Kx value using the POPC:POPG mixture. 
The higher propensity to partition in native E. coli lipid extract can be explained by both 
charge effects and other constituents such as phosphatidylethanolamine (67% wt/wt) 
and cardiolipin that may anchor the peptide to the membrane. Analogous results have 
been reported by Vogel and co-workers for indolicin and tritrpticin in interaction with model 
and natural membranes.206 
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2.3.4 Calcein release studies 
Membrane permeabilization by Cnd was also studied by monitoring the increase 
of calcein fluorescence upon addition of peptide. As calcein has excitation and emission 
wavelengths of 490 nm and 520 nm, respectively, its leakage from POPC, POPC/POPG 
(70/30 wt/wt) and E. coli extract LUVs was measured as a function of time at different 
peptide concentrations ranging from 0.1 to 1.0 μM. When a high concentration of calcein 
is present in the LUVs, the fluorescence is self-quenched. After addition of Cnd to the 
calcein-loaded vesicles, a gradual release of calcein induced by the peptide/lipid bilayers 
interaction is observed. To confirm that calcein release was due to vesicle/peptide 
interaction and not to vesicle rupture, the integrity of the lipid vesicles was determined by 
right angle light scattering. In Table 2, the relative leakage capabilities of Cnd with different 
liposome vesicles are reported as function of lipid/peptide ratio. We employed POPC 
vesicles, negatively charged vesicles containing POPC/POPG (70/30 w/w) to simulate 
bacterial cell membranes, and E. coli extract vesicles. The relative percentage of leakage 
shows that the dose-response of Cnd-induced calcein leakage is more effective in the 
presence of negatively charged membranes, especially at a low peptide/lipid ratio. The 
minor leakage capability observed for E. coli lipid extract was also reported by Vogel et 
al.206 for tryptophan rich cathelicidin antimicrobial peptides; this was attributed to the 
complexity of the E. coli extract making vesicles less prone to disruption. 
We also examined the kinetics of leakage using a method developed by Tatulian 
and co-workers.192 Figure 6 shows the fractional release of calcein from a solution 
containing 25 μM of POPC/POPG vesicles as an example of peptide-induced calcein 
release. Upon addition of the peptide, a gradual increase of fluorescence due to calcein 
release is observed until fluorescence reaches the equilibrium, Feq. 
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The values of the kinetic parameters accounting for the fast and the slow 
components of the process are reported in Table S1. The kinetic constants depend on the 
membrane charge and peptide concentrations and range from 0.2–2.0 min and 7–59 min 
for the fast and the slow components. 
 
2.3.5 Fluorescence quenching experiments 
The degree of peptide exposure to the bulk solvent was assessed through Tyr-6 
fluorescence quenching experiments using iodide ions as a quencher.194 Figure 7 shows 
the Stern–Volmer plots for iodide quenching of Cnd in the absence and presence of 
POPC, POPC/POPG and E. coli extract. 
The data are corrected for both dilution and absorption of fluorophores. The iodide 
quenching curves follow a linear correlation with the KI concentration, indicative of 
collisional quenching. The KSV values, obtained from the slopes of the curves and 
accounting for the dynamic quenching, are reported in Table 3. 
As expected, the KSV values of are higher in buffer solution (KSV ≈ 10 M− 1) than in 
the presence of vesicles (KSV ≈ 3 M− 1), with the slopes determined in the presence of 
vesicles ~3–6 fold smaller than in buffer only. This implies that Tyr-6 has a higher 
accessibility to solvent in the absence of lipid membranes, and suggests that Tyr-6 
partitions at the interfacial region of the lipid bilayer. As for the partition constant, the 
quenching experiments show that the peptide interacts more strongly with charged lipids 
and with native E. coli membranes than with POPC. 
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2.3.6 NMR studies of chionodracine in micelles 
For the structural studies, Cnd was reconstituted in DPC micelles.207-209 Sequence 
specific resonance assignments were obtained by a combination of 2D [1H–1H]-TOCSY 
and [1H–1H]-NOESY spectra. From these spectra, we assigned most of the resonances 
and NOE connectivities. Due to slow tumbling of the peptide in micelles, we were not able 
to measure the J coupling constants.207-210 The complete resonance assignment is given 
in Table S2. In the TOCSY experiment, we were able to assign most of the fingerprint 
region containing Hα–HN cross-peaks. However, only a few spin systems show 
correlations between the amide and the side chains due to the inefficient relay of 
magnetization. The peptide spin system assignment was achieved following the NOESY-
walk method reported by Wuthrich.201 From the analysis of the NOESY spectra at 300 ms, 
a total of 240 NOEs (75 intra-residue and 165 inter-residue) were assigned. Figure S3 
shows the summary of NMR data and NOEs connectivities obtained for the fingerprint 
region Hα–HN, the backbone NOE patterns, and the chemical shift index for Hα.211 We 
assigned several dNN (i,i + 1) and dαN (i,i + 1) along the peptide backbone, as well as dαN 
(i,i + 2). Connectivities diagnostic of an α-helical conformation, such as dαN (i,i + 3), dαN (i,i 
+ 4), dNN (i,i + 3) and dαβ (i,i + 3), were detected along the entire peptide backbone, 
especially in the region between residues 5 and 20. From the analysis of the natural 
abundance 13C-edited HSQC, we were able to resolve the amino acid spin system and 
assign Cα and Cβ for the different residues. NMR chemical shifts are strongly related to 
the secondary structure of proteins and peptides and can be used to calculate the 
structures.211,212 To obtain Cnd peptide backbone torsion angles, we input the chemical 
shifts into TALOS+.202 Figure S4 (C) reports the RCI-S2, Random Coil Index derived order 
parameter S2,212 predicting protein flexibility, and the ANN-predicted secondary structure 
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calculated from backbone chemical shifts of Hα, HN, Cα and Cβ using TALOS+.202 
According to this method, RCI-S2 values less than 0.5 indicate dynamic residues. In 
Figure S4, the bar length is proportional to the probability of the residues to be in either a 
helix (negative values) or beta-sheet (positive values) conformation. For the Cnd peptide, 
the average order parameter for residues 5–20 is ~ 0.8, except for the C-terminal region, 
which is predicted to be disordered. The conformers obtained from the XPLOR-NIH 
calculations203 confirmed this prediction. Figure 8 displays the superposition of the 40 
lowest energy conformers obtained from the structure calculations as well as the average 
structure. As shown in Figure 8, the well-defined ensemble is arranged in an α-helical 
conformation between residues 5 through 20, featuring a classical amphipathic α-helix. 
The superposition of backbone atoms between residues H4 through L20 gives a 
RMSD of 0.30 ± 0.17 Å, and a RMSD of 0.92 ± 0.28 Å for the heavy atoms. From the 
analysis of the amphipathic helix, there is evidence that hydrophobic residues are on the 
face of the peptide that is likely closest to the lipid bilayer. The statistics for the 40 best 
NMR structures of Cnd in DPC micelles are reported in Table S3. 
 
2.4 Discussion and conclusion 
Interest in studying AMPs has grown significantly in recent years due to the fact 
that increasing bacterial resistance to conventional antibiotics is becoming a global 
emergency.26,27 The majority of AMPs share the ability to kill a broad spectrum of 
prokaryotic cells by interacting with and disrupting bacterial cell membranes.21,213-215 In 
addition, several AMPs are involved in modulating immune and inflammatory 
responses.216,217 AMPs’ broad spectrum of activity, as well as the obstacles they present 
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to the development of resistance, makes them an important candidate for a valid 
alternative to conventional antibiotics.25 In fact, some AMPs are already used, in drug 
formulation, to topically treat infections.26 Recent studies, reviewed by Hancock, show that 
AMPs also have immunomodulatory properties.217 
Generally, AMPs such as piscidins are cationic, small (15–45 residues), and 
amphipathic, with about 50% of their residues hydrophobic to facilitate the interaction with 
cell membranes.218,219 Since the first antimicrobial peptide, nisin was isolated in 1947, 
more than 1800 AMPs have been identified, some natively expressed and others 
synthesized and tested against different microorganisms.220 Unfortunately, a unified 
mechanism of action of AMPs has not yet been found. The only way to understand their 
biological function is to combine functional assays with detailed structural studies.207-
209,221,222 
Peptides derived from fish are attracting growing attention, as they are active at 
high salt concentrations and a wide range of temperatures, making them ideal candidates 
for antimicrobial drugs. Pardaxin from Moses sole (Pardachirus marmoratus) was the first 
fish antimicrobial peptide to be discovered and characterized.207,223 Thereafter, many 
peptides showing a broad-spectrum of antimicrobial activity were isolated from fish, such 
as misgurin from the loach Misgurnus anguillicaudatus,224 pleurocidin from winter flounder 
(Pleuronectes americanus),225 and piscidins from hybrid striped bass (Morone chrysops 
female and Morone saxatilis male).178 
The TEM images show the formation of distinct pores (35–50 nm in diameter), 
highly localized at possible points of peptide aggregation. This mode of permeabilization 
supports the macroscopic current and single-channel measurements carried out by 
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Campagna and co-workers on piscidin-1,175 supporting the formation of discrete pores. 
Moreover, the presence of completely fragmented membranes suggests a carpet-like 
mechanism of action for Cnd. However, Cotten and coworkers emphasize for piscidins 1 
and 3 that is difficult to discern between these two mechanism suggesting the carpe model 
as an extension of pore mechanism.87 The affinity for synthetic bilayers, quantified via the 
intrinsic fluorescence quantum yield of the native Tyr-6 of Cnd, shows that the peptide has 
a piscidin-like behavior with the cationic residues preferentially targeting negative charged 
lipid membranes. As with the other piscidins, Cnd undergoes a disorder-to-order transition 
into a well-defined amphipathic α-helical conformation. The amphipathic α-helix motif is a 
relevant and well-known membrane-binding motif in which both hydrophilic and 
hydrophobic sites are involved in membrane binding. For instance, an amphipathic helix 
form from residue 2 through 22 has also been found for the 22 residue analog peptide 
piscidin-1 in SDS micelles.226 The presence of an amphipathic helix for the analogues 
piscidin-1 and piscidin-3 has been confirmed by ssNMR studies in lipid bilayer.87,88,90 Using 
ssNMR spectroscopy and MD simulation, Cotten and co-workers87 showed that piscidin-
1 and piscidin-3 insert and rotate in the bilayer; furthermore, due to the presence of the 
aromatic residues at the N-terminus, it is more deeply inserted in the bilayer than the C-
terminus. For Cnd, NMR derived structures (Fig. 8) indicated that Cnd interacts with the 
lipid membrane so that the non-polar face is in contact with the hydrophobic portion of the 
membrane and the polar residues are oriented toward the solvent.227 This evidence is also 
confirmed by the Tyr-6 quenching studies. As reported in Table 3, Tyr-6 is much less 
accessible to the solvent upon binding with lipid vesicles, and the Stern–Volmer constant 
is 3–6 fold smaller, depending on the vesicles, than in buffer. The decrease in accessibility 
of the fluorophore to the quencher can be explained by the fact that, upon binding, the N-
terminus is deeply inserted into the lipid bilayer due to the presence of the two 
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phenylalanine residues in positions 1 and 2. Moreover, the presence of anionic lipids 
lowers the Gibbs partition energy by about 4 kJ/mol moving from the zwitterionic POPC to 
the anionic mixture (POPC/POPG 70:30). We speculate that following binding to the 
membrane surface, there is a perturbation of the lipid membrane and the formation of 
pores and membrane fragmentation that concur to the leakage of the cell content. To this 
extent, leakage measurements reveal the ability of Cnd to induce calcein release from 
lipid vesicles in a dose-dependent manner, based on both peptide-to-lipid ratio as well as 
the type of lipids used (Fig. 4). The efflux rates increase in the presence of a higher 
peptide/lipid ratio and in the presence of anionic lipids, likely as a consequence of better 
binding, as confirmed by higher values of Kx. At low peptide to lipid ratios the induced 
leakage is low, while upon increasing this ratio the leakage also drastically increases.193 
In conclusion, the combination of TEM, fluorescence data, solution NMR 
spectroscopy, and lipid binding assays of Cnd support a mechanism of action in which the 
mature peptide is essentially unstructured and adopts a canonical α-helical structure upon 
interaction with lipid membranes, with a preference toward charged lipids and E. coli 
extracts. The TEM images and the NMR data suggest that the initial adsorption of the 
peptide on membranes is followed by the recruiting of other monomers, forming well-
defined pores that perforate both inner and outer membranes. The latter mechanism 
occurs together with an extensive membrane fragmentation that concurs to killing bacterial 
cells. Given the weak hemolytic activity of Cnd, these data suggest that this peptide could 
constitute a great starting point for the development of more specific and potent 
antimicrobial agents. 
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Figure 1. Primary sequences for Cnd and other piscidin antimicrobial peptides with 
sequence homology highlighted.  
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Figure 2. TEM micrographs of ultrathin sections from Psychrobacter sp. TAD1. (A) 
General view of cells showing the OMVs interspersed among bacteria (arrow heads). (B) 
Magnified view of cells surrounded by two membranous structures: the inner membrane 
and the outer membrane. (C) Image showing the OMVs protruding from the bacterial outer 
membrane. (D) Bacteria showing membrane damage after 10 min of treatment (arrows). 
(E) Higher magnification of damaged bacteria showing discrete pores (arrows) together 
with membrane fragmentation. (F) Dividing cells with leakage of cellular contents after 
10 min of treatment. (G) A detail of fragments of destroyed cellular membranes (arrows) 
after 10 min of treatment. IM: inner membrane; OM: outer membrane. Scale bar: 2 μm in 
(A); 250 nm in (B); 250 nm in (C); 2 μm in (D); 2 μm in (E); 500 nm in (F); 1 μm in (G). 
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Figure 3. Percentage of Psychrobacter sp. TAD1 damaged bacteria. TEM images were 
analyzed to determine the percentage of mortality both in controls and treated cells (at the 
same magnification), by counting a total number of 50,000 cells. Data were collected at 
different times (0, 10 and 180 min in) and only cells with completely fragmented 
membranes were considered. Numerical results are presented as mean ± SD. The level 
for accepted statistical significance was P < 0.01. Significantly different (P < 0.01) from: 
(a) peptide 0 min, (b) control 0 min, (c) control 10 min, and (d) control 180 min. 
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Figure 4. Permeabilization of E. coli (A) and TAD1 (B) outer membrane by Cnd. 
Fluorescence of ANS equilibrated with cells and in the presence of increasing amount of 
Cnd peptide from 1.0 through 15 μM. The cell density measured at OD600 was 1.2. 
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Figure 5. Binding isotherms for Cnd upon addition of increasing amount of lipid vesicles. 
The concentration of peptide was 10.0 μM. 
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Peptide Concentration Lipid Composition Kx ΔG (kJ/mol) 
 POPC (3.43 ± 0.26)×104 -25.9 
1.0 µM POPC/POPG (70/30 w/w) (4.91 ± 0.29)×104 -26.7 
 Total E. coli extract (1.83 ± 0.08)×105 -30.0 
 
Table 1. Partition parameters for Cnd in the presence of different mixtures of POPC/POPG 
and E.coli total lipid extract. 
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Peptide/lipid 
(molar ratio) 
Relative leakage 
PC LUVs 
Relative leakage 
POPC/POPG (70/30) LUVs 
Relative leakage  E.coli 
total extract LUVs 
1/25 63% 100% 18% 
1/50 26% 90% 13% 
1/100 11% 60% 9% 
 
Table 2. Relative leakage capabilities of Cnd, at different peptide/lipid ratios, in the 
presence of 100% POPC, 70/30 POPC/POPG and 100% total E.coli lipid extract LUVs. 
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Figure 6. Kinetics of calcein efflux from LUVs after addition of different amount of Cnd 
from 0.10 μM through 1.0 μM. The curves are the experimental data normalized by Triton 
X-100. (A) Kinetics curves for POPC LUVs (25.0 μM) at different peptide concentrations; 
(B) kinetics curves for POPC LUVs (50.0 μM); (C) kinetics curves for POPC/POPG (70/30) 
LUVs (25.0 μM) and (D) kinetics curves for POPC/POPG (70/30) LUVs (50.0 μM). Note 
the difference in time scale for different panels. 
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Table 3. KI quenching. Stern–Volmer quenching constant (KSV) and percentage of iodide 
quenching for Cnd in the presence of different lipid vesicles. The peptide/lipid molar ratio 
was 1:100 in all cases. 
  
 KSV  (M-1) 1/KSV  (M) 
Percent of 
quenching 
Buffer 10.4 ± 0.2 0.096 100 
POPC (LUVs) 2.9 ± 0.1 0.340 28.4 
POPC-POPG (70:30 LUVs) 2.5 ± 0.1 0.408 23.6 
E. coli (LUVs) 1.6 ± 0.2 0.625 15.4 
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Figure 7. Stern–Volmer plots for the quenching of Tyrosine 6 of Cnd by KI in aqueous 
buffer and in the presence of POPC, POPC/POPG (70/30) and E. coli total extract LUVs. 
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Figure 8. NMR structural models of Cnd. (A) Histogram of the backbone RMSD versus 
residues for the final 40 Cnd conformers, superimposing heavy atoms for residues 2–20; 
(B) conformational ensemble showing the convergence of the structures for heavy atoms 
of the backbone; (C) representative structure of Cnd showing the two faces of the 
amphipathic helix. The hydrophobic residues are represented in orange and the 
hydrophilic residues in green. 
  62 
2.5 Supplemental Data 
2.5.1 Supplemental tables. 
 
Lipid vesicle concentration 25 µM  
 
 
Lipid vesicle concentration 50 µM 
 
[P] 
µM 
Feq 
PC 
 
PC/PG 
σ 1 
PC 
 
PC/PG 
σ 2 
PC 
 
PC/PG 
k1(s-1) 
PC 
 
PC/PG 
k2(s-1) 
PC 
 
PC/PG 
0.10 0.0917 0.2418 0.0261 0.1391 0.0228 0.0322 0.000275 0.001436 0.00359 0.01082 
0.25 0.0970 0.3684 0.0228 0.1782 0.0298 0.0859 0.001250 0.000792 0.00998 0.00713 
0.50 0.1448 0.5775 0.0412 0.1069 0.0317 0.2065 0.001064 0.002399 0.00971 0.01678 
1.00 0.2448 0.9096 0.1014 0.1501 0.0554 0.3614 0.000481 0.002130 0.00557 0.03475 
 
Table S1. Kinetic parameters for calcein efflux from LUVs of different lipid composition 
upon addition of increasing amount of Cnd. The parameters are derived from fitting data 
with the equation: )exp()exp(
2211
tkatkaFF
eqt
  . 
 
 
 
  
[P] 
µM 
Feq 
PC 
 
PC/PG 
σ1 
PC 
 
PC/PG 
σ 2 
PC 
 
PC/PG 
k1(s-1) 
PC 
 
PC/PG 
k2(s-1) 
PC 
 
PC/PG 
0.10 0.1252 0.3787 0.0360 0.1454 0.0534 0.1272 0.001103 0.001465 0.00515 0.00855 
0.25 0.1500 0.5856 0.0487 0.1741 0.0241 0.2249 0.002249 0.003544 0.02263 0.01557 
0.50 0.3355 0.8131 0.1126 0.1431 0.0757 0.2254 0.000264 0.005121 0.00362 0.08149 
1.00 0.6414 0.9500 0.2387 0.1479 0.1667 0.1652 0.000408 0.018941 0.00611 0.11511 
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Residue NH (ppm) CαH (ppm) CβH (ppm) Others (ppm) 
F1 NA 4.051  δ-H  
ε-H  
ζ-H NA 
F2 8.575 4.158  δ-H  
ε-H  
ζ-H NA 
G3 8.229 3.979   
H4 8.567 4.154 3.178/3.108 δ -H     7.014 
L5 8.066 4.061 1.695 γ-CH    1.596 
δ-CH3   0.892 
Y6 8.397 4.518 3.195 δ-H          7.020 
ε-H       6.794 
R7 8.334 3.966 1.906 γ-CH2   1.669 
δ-CH2   3.270  
G8 8.545 3.758   
I9 8.389 3.961 1.924 γ1-CH2 1.671 
γ2-CH3 1.593 
δ-CH3     0.909 
T10 8.185 3.766 4.187 γ-CH3     1.094 
S11 7.875 4.292 4.140/4.029  
V12 8.013 4.292 2.365 γ-CH2     1.119 
γ-CH3    0.972 
V13 8.398 3.528 2.245 γ-CH2    1.095 
γ-CH3    0.905 
K14 8.185 4.094 1.938 γ-CH2    1.423 
δ-CH2    1.832 
ε-CH2       2.956 
ε-NH3+  7.128 
  64 
H15 8.162 4.541 3.355 δ-H       7.204 
V16 8.611 3.752 2.264 γ-CH2   1.106 
δ-CH2    0.974 
H17 8.629 4.300 3.394/3.304 δ-H       7.2414 
G18 8.225 3.883   
L19 7.759 4.235 1.941 γ-CH     1.588 
δ-CH3     0.925 
L20 7.704 4.342 1.807 γ-CH     1.638 
δ-CH3     0.891 
S21 7.806 4.429 3.807  
G22 7.908 3.792   
 
Table S2. Resonance assignments of 1H chemical shifts of Cnd in DPC 
detergent micelles using solution NMR experiments. 
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Table S3. Statistics for the 40 best NMR structures of Cnd in DPC micelles. 
 
Parameter Value 
Distance and Angle Restraints 
Total NOEs 
Intraresidual 
Interresidual 
Angles 
 
240 
75 
165 
32 
Hydrogen bond restraints 10 
Total restraints per residue  12.8 
Statistics for Calculated Structures 
R.M.S.D. (Å) 
Backbone 
All Heavy Atoms 
 
0.30 ± 0.17 
0.92 ± 0.28 
 
Analysis (performed with Molprobity) 
% residues in most favored regions 
% residues in additional allowed regions 
% residues in generally allowed regions 
% residues in disallowed regions 
83.6 
11.1 
1.6 
3.7 
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2.5.2 Supporting Figures. 
 
 
Figure S1. Partition experiments. Cnd fluorescence in absence and presence of 
increasing concentration of LUVs (A) POPC (B) POPC/POPG (70/30). 
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Figure S2. Iodide quenching experiments. Cnd intrinsic fluorescence in absence and 
presence of increasing amount of KI. 
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Figure S3. Fingerprint region of Cnd extracted from a 2D [1H-1H] NOESY experiment at 
300 ms mixing time. The sample consisted of 1.5 mM Cnd reconstituted into phosphate 
buffer containing 300 mM DPC at pH 6.5. 
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Figure S4.  Summary of NMR structural parameters.  (A) Backbone NOEs pattern for Cnd 
in DPC micelles. Correlations indicated with thick lines correspond to strong NOE, 
whereas correlation indicated with thinner lines correspond to medium or weak NOEs. (B) 
Predicted order parameter RCI-S2 (residues with values less than 0.5 are dynamics) and 
(C) predicted secondary structure calculated using TALOS+. Negative bars indicate the 
helix structure while the height of the bars specifies the probability assigned using a neural 
network secondary structure prediction.   
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Chapter 3 - Ca2+ ATPase Conformational Transitions in Lipid Bilayers 
Mapped by Site-directed Ethylation and Solid-State NMR 
 
 
Reprinted with permission and adapted from:  
Vitaly V. Vostrikov, Martin Gustavsson, Tata Gopinath, Dan Mullen, Alysha A. 
Dicke, Vincent Truong, and Gianluigi Veglia. Ca2+ ATPase Conformational 
Transitions in Lipid Bilayers Mapped by Site-directed Ethylation and Solid-State 
NMR. ACS Chem. Biol. 2016; 11(2):329–334. Copyright (2016) American 
Chemical Society. 
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Abstract 
To transmit signals across cellular compartments, many membrane-embedded enzymes 
undergo extensive conformational rearrangements. Monitoring these events in lipid 
bilayers by NMR at atomic resolution has been challenging due to the large size of these 
systems. It is further exacerbated for large mammalian proteins that are difficult to express 
and label with NMR-active isotopes. Here, we synthesized and engineered 13C ethyl 
groups on native cysteines to map the structural transitions of the sarcoplasmic reticulum 
Ca2+-ATPase, a 110 kDa transmembrane enzyme that transports Ca2+ into the 
sarcoplasmic reticulum. Using magic angle spinning NMR, we monitored the chemical 
shifts of the methylene and methyl groups of the derivatized cysteine residues along the 
major steps of the enzymatic cycle. The methylene chemical shifts are sensitive to the 
ATPase conformational changes induced upon nucleotide and Ca2+ ion binding and are 
ideal probes for active and inactive states of the enzyme. This new approach is extendable 
to large mammalian enzymes and signaling proteins with native or engineered cysteine 
residues in their amino acid sequence.  
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3.1 Introduction 
Cell signaling events are mediated by membrane-bound enzymes and proteins 
that transmit their messages across lipid membranes through chemical, structural, and/or 
dynamical changes. Since membrane proteins are difficult to crystallize in lipid 
membranes, solid-state NMR (ssNMR) spectroscopy is the ideal high-resolution 
spectroscopic technique to monitor structural changes in liquid crystalline lipid 
membranes.77,78,228 When the proteins or protein complexes exceed 100 kDa, the analysis 
of structural transitions becomes cumbersome as the number of structural probes 
(resonances) crowds the NMR spectra. For solution NMR spectroscopy, Kay and co-
workers introduced recombinant protein expression protocols that enable amino acid 
specific 13C methyl labeling.229,230 The higher gyromagnetic ratio of 13C with respect to 15N 
in concert with longer relaxation times of the methyl groups makes it possible to image the 
methyl fingerprint region of larger proteins.229,231 For example, such a labeling technique 
was used to monitor the conformational transitions of large enzymes by solution 
NMR.232 For larger globular proteins containing reduced cysteine residues, it is also 
possible to covalently link 13C-labeled methyl groups by site-directed labeling, incubating 
the protein with 13C methylmethanethiosulfonate (MMTS).233 Similar approaches have 
been utilized to probe the conformational landscape of membrane proteins by modification 
of Lys side chains,234-236 or by introducing 19F probes.237-240 To date, these studies have 
been limited to detergent micelles that can affect protein structure, topology, and function 
compared to native lipids.241-244  
Larger eukaryotic membrane proteins are very challenging to express 
recombinantly in amounts required for NMR spectroscopy.245 Nonetheless, their structural 
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and dynamic transitions could still be monitored by NMR using cysteine reductive 
methylation.233 However, this method presents severe spectroscopic challenges as the 1H 
signals of nondeuterated proteins are typically broad and unresolved.246 Moreover, the 13C 
background signals arising from natural abundance 13C from proteins and lipids 
complicate the appearance of the spectra. To overcome these problems, we 
synthesized 13C-ethylmethanethiosulfonate (13C-EMTS) and used it to alkylate the native 
Cys side chains (Fig. 1). This approach has three major merits: (i) It enables one to filter 
out the natural abundance 13C signals using dipolar assisted rotational resonance (DARR) 
experiments,247 making it possible to study membrane proteins in native lipid bilayers. (ii) 
It provides better resolution of the engineered aliphatic resonances with respect to methyl 
groups. (iii) The 13C-EMTS probe is small and relatively nonperturbing, and labeling can 
be carried out in the aqueous milieu, retaining enzymatic activity. 
As a proof-of-principle, we used site-directed ethyl labeling to monitor the 
conformational transitions of the sarcoplasmic reticulum Ca2+-ATPase (SERCA), 
EC:3.6.3.8, a 110 kDa integral membrane protein that plays a key role in muscle 
contractility.248,249 To monitor SERCA’s conformational transitions, we labeled the most 
reactive cysteine residues with 13C-EMTS and followed the chemical shift changes of both 
CH2 and CH3 signals by ssNMR DARR experiments. To assign the resonances, we 
employed a combination of paramagnetic relaxation enhancement (PRE) experiments. 
We were able to obtain domain specific assignments for all of the resonances in the P and 
N domains of SERCA, including two unambiguous assignments for ethyl groups linked to 
C674 and C636 of the P domain, defining the NMR signatures for the different 
conformational states of the enzyme. 
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3.2 Materials and Methods  
The synthesis of 13C-EMTS was accomplished by refluxing equimolar amounts 
of 13C bromoethane and potassium methanethiosulfonate for 5 h in ethanol (Figs. 
1 and S1). The resulting product was filtered, and the solvent was removed by 
evaporation. The final product was identified by solution NMR and used without further 
purification. To label the ATPase with EMTS, we incubated 9 μM C12E8-solubilized SERCA 
purified from rabbit skeletal muscle250 in reconstitution buffer (20 mM HEPES, 100 mM 
KCl, 1 mM Mg2+, 5% glycerol, 0.02% NaN3) with 45 μM (5-fold molar excess) of EMTS for 
3 h. Enzymatic activity of labeled SERCA was measured by ATP hydrolysis assay.251 The 
incubation time and the EMTS concentrations were varied to minimize activity loss of 
SERCA. Under conditions of 5-fold excess of EMTS relative to SERCA and 3 h incubation, 
the ATPase retains full activity (Fig. 1). Additionally, we have tested SERCA labeling with 
10-fold and 20-fold excess of EMTS to assess whether all the cysteine residues in the 
enzyme are accessible to the labeling reagent. The enzymatic assay does not show 
SERCA activity in the presence of large excess of EMTS, suggesting that the least reactive 
cysteines are essential for the SERCA function (Fig. S2). 
For SERCA reconstitution in lipid membranes, 9 mg of DMPC-d54 were solubilized 
in 18 mg of C12E8 and added to the ATPase. Detergent was removed by incubation with a 
30-fold weight excess of biobeads for 3 h. The sample was centrifuged at 100 000g, and 
the pellet was resuspended in reconstitution buffer, dialyzed twice to remove any 
unreacted EMTS, and pelleted down at 100 000g. The proteoliposome pellet was 
resuspended in 1 mL of reconstitution buffer with appropriate ligands, sedimented by 
ultracentrifugation at 350 000g for 20 h, and the resulting hydrated pellet was transferred 
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to a 3.2 mm MAS rotor for NMR experiments. The ligands used to induce the different 
SERCA conformations were: 5 mM CaCl2 (E1-Ca2+), 2.5 mM AMPPCP (E2-ATP), 5 mM 
CaCl2, and 2.5 mM AMPPCP (E1-Ca2+-ATP) or 5 mM CaCl2, 2.0 mM AlCl3, 2.5 mM ADP, 
and 20 mM NaF (E1-Ca2+∼P∼ADP). To increase the resolution, a constant-time version 
of the DARR experiment, [13C,13C]-CT-DARR, was used.247,252 The spectrum was acquired 
at 4 °C with a spinning rate of 10 kHz on a 600 MHz Varian spectrometer. Acquisition 
parameters were 4000 points with a spectral width of 100 kHz (direct dimension). The 
corresponding values in the indirect dimension were 36 points and 5 kHz. A total of 1024 
scans were acquired with 800 μs CP transfer, 100 ms DARR mixing time, and ωRF/(2π) = 
100 kHz TPPM decoupling. 
 
3.3 Results and Discussion 
The spectrum of labeled SERCA in DMPC bilayers obtained with a 5-fold excess 
of EMTS is shown in Figure 1. The SERCA spectrum with nonhydrolyzable ATP analog 
AMPPCP without Ca2+ shows well-resolved cross peaks between CH2 and CH3 moieties 
of the probe. Importantly, these are the only off-diagonal signals in the spectrum, as DARR 
transfer occurs only between adjacent 13C nuclei, eliminating the natural abundance 13C 
resonances of lipids and SERCA, which dominate one-dimensional 13C spectra.253 Thus, 
the EMTS labeling strategy enables spectral editing in 2D, enhancing the resolution. Since 
the transfer of magnetization in the DARR experiment is mediated by dipolar couplings, it 
is sensitive toward the mostly rigid groups. The differential mobility of the NMR probes can 
lead to distinct efficiencies of magnetization transfer, manifested as the variations in the 
peak intensity. The dynamics of the NMR probes can be further evaluated and quantified 
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with the appropriate techniques.254,255 The ethyl cross peaks are clearly visible in the 
spectrum at ∼16 ppm (CH3−) and ∼34 ppm (−CH2−) with much greater resolution in the 
−CH2– resonances. To identify the ethylated Cys residues of SERCA, we utilized trypsin 
digestion in combination with electrospray ionization tandem mass spectrometry (LC-
MS/MS). We detected small peptides corresponding to 16 out of 23 Cys residues of 
SERCA, covering all Cys in the cytoplasmic P, N, and A domains. A high yield of Cys 
ethylation was achieved at six sites: 364, 471, 498, 561, 636, and 674 (Figs. S3–S5). To 
estimate the labeling efficiency, a large excess of iodoacetamide was added to SERCA 
immediately after the ethylation reaction and prior to trypsin cleavage. For two of the 
modified Cys, we detected carbamidomethylated (CAM) peptides with higher relative 
abundance than of the ethylated peptides (Fig. S5). Thus, we conclude that these 
residues have much lower percentage of ethylation and the peaks in the [13C–13C]-CT-
DARR spectrum correspond to Cys 364, 471, 498, 561, 674, and 636 (Fig. 2). 
While the DARR experiment enables one to measure short-range distances 
between the probes,247,256 the distance separation of greater than 10 Å between the 
labeled cysteines precludes its use for distance measurement in the case of SERCA. To 
obtain domain specific assignments of the ethyl group fingerprint, we incubated SERCA 
in the E2-ATP state with various spin labels to selectively quench the NMR signals based 
on their proximity to the unpaired electron using paramagnetic relaxation enhancement 
(PRE; Fig. 3). Specifically, we engineered the TEMPO spin-label coupled to the lipid 
headgroup or to the 3′/5′ hydroxyl groups of the nucleotide (Fig. S1). Additionally, we 
selectively attached iodoacetamide TEMPO to C674, as described previously,257 and 
performed the experiments with the oxidized and reduced spin label. The NMR spectra of 
the ethyl group fingerprint and EPR spectra corresponding to the spin-labels are shown 
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in Figure 3. Both DOPE-TEMPO and C674-MTSL are close to the lipid–water interface 
and quench the ethyl groups of the Cys in the P domain. The spin labeled nucleotide, 
ADP-TEMPO, bound in the N domain away from the membrane, partially quenched 
residues both in the P and N domains. Based on the quenching pattern, we assigned the 
resonances between 33.5 and 34.5 ppm to the ethyl groups cross-linked to the cysteines 
in the N-domain, whereas the resonances that are in the range between 34.5 and 35 ppm 
and 32.5 and 33.5 ppm to those of the P domain. Furthermore, we employed 10 mM 
ascorbic acid to reduce the free radical of C674-MTSL to hydroxylamine. The quenched 
spin label does not exert any effect on NMR relaxation of the adjacent 13C nuclei, and the 
only missing signal can be assigned to the ethyl group on C674. Indeed, the 34.8 ppm 
peak is absent in the NMR spectrum, and therefore it is assigned to C674. Consequently, 
the remaining P-domain resonance at 33.1 ppm is assigned to C636. 
The labeled Cys in the P and N domains of SERCA are ideally positioned to probe 
the allosteric communication between Ca2+ binding in the TM domain and nucleotide 
binding in the cytoplasmic domain (Figs. S6–S7). It has been proposed that the enzymatic 
cycle of the ATPase comprises several different conformational states.249,258 For example, 
the structures of SERCA in the Ca2+-free nucleotide-bound (E2-ATP),259 Ca2+- and 
nucleotide-bound (E1-Ca2+-ATP),260 and Ca2+-bound nucleotide-free (E1-Ca2+)261 states 
show distinct conformations of the cytoplasmic domains.262-264 To test whether the 13C-
EMTS labeled sites are sensitive to the conformational transitions of SERCA, we 
mimicked these major states of the enzymatic cycle,150 saturating the enzyme with 
AMPPCP, ADP/AlF4, or Ca2+. The ethyl group signatures of the enzyme’s states display 
pronounced differences. In the Ca2+-free form, SERCA populates the E2 conformational 
state, while the addition of Ca2+ shifts the equilibrium to the E1 state.150,258 Upon 
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Ca2+ addition, the P domain peaks of the E2 state spectrum change substantially (Fig. 4). 
These peaks are sensitive probes for tracing the enzyme’s interconversion between the 
E1/E2 states. 
The center of mass of the cytoplasmic domains has the largest separation in the 
E1-Ca2+structure (Fig. 4), which has been predicted to be highly dynamic.262,263 It is 
notable that the resonance pattern and signal intensity of SERCA in this state differ 
significantly from the rest of the spectra. We speculate this may be attributed to the distinct 
motion time scale of this state. During the E1/E2 transition, the N-domain undergoes 
rotation and translation, with the ATP molecule bridging the N and P domains, stabilizing 
the enzyme. Accordingly, in the E2-ATP state, we observed all of the Cys ethyl groups, 
suggesting reduced conformational dynamics. The crystal structures of the E1-Ca2+-ATP 
and E1-Ca2+∼P∼ADP states are nearly identical (1.2 Å RMSD), and one can expect the 
ethyl fingerprints to be similar. Nevertheless, the pattern differs in both N-domain signals 
as well as C636, indicating structural and/or dynamic changes of SERCA going from ATP-
bound to the transition mimic ADP·P-bound state. 
The activity of SERCA is regulated by several factors: lipids,44 other 
proteins,113,265 and post-translational modifications.266 The associated structural changes 
have been monitored using site-directed spin labeling of SERCA’s Cys residues.257,267-
275 Although most of the chemical modifications of SERCA’s Cys residues did not 
completely inactivate this enzyme, their size and mobility represent a problem for the 
accurate distance measurement, or monitoring allosteric coupling between ATP hydrolysis 
and Ca2+ transport.269-271,273,276,277 These problems are even more apparent when small 
molecule inhibitors or activators are screened for drug discovery.278 In such cases, the 
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combination of ethylation and ssNMR can provide a powerful approach to monitor ligand-
induced conformational changes with SERCA function in a native membrane environment. 
In summary, we demonstrated that site-directed ethyl labeling in combination with 
paramagnetic spin-labeling and solid-state NMR is a powerful method to study SERCA in 
lipid bilayers under fully functional conditions. Paramagnetic relaxation enhancement 
strategy enabled domain-specific assignments of the spectra, with two resonances 
unambiguously assigned to the individual cysteine residues. Importantly, the ethyl 
chemical shifts are sensitive to conformational changes of the enzyme, giving distinct 
signatures for the major structural states and will constitute specific reporters for active 
and inhibited states of the ATPase. This method will be widely applicable to monitor the 
conformational states of large proteins or protein complexes, purified from natural sources. 
It can be easily extended to smaller proteins and receptors expressed recombinantly, 
including GPCRs, where site-directed mutagenesis can make the assignments 
unambiguous. Moreover, it can be utilized to monitor dynamic changes via nuclear spin 
relaxation experiments.  
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Figure 1. (a) Synthesis of 13C EMTS and its usage for the labeling of cysteines of SERCA. 
(b) [13C,13C]-CT-DARR spectrum of 13C-EMTS labeled SERCA. (c) Normalized ATPase 
activity of the ethylated SERCA: reaction with 5-fold excess of EMTS did not modify the 
activity of the enzyme. 
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Figure 2. Mass spectrometry of 13C-EMTS labeled SERCA. (a) Representative LC-MS 
chromatograms of a tryptic peptide with EMTS (+62) or CAM (+57) modifications. (b) MS2 
fragmentation of the indicated peaks was used to confirm the peptide identity. (c) Cys in 
SERCA that are preferentially labeled (orange), partially labeled (yellow), and not labeled 
(white) with EMTS. 
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Figure 3. (a) Crystal structure of SERCA with the spin label positions indicated. (b–e) 
NMR and EPR spectra of the ethyl labeled enzyme with the spin labels indicated in Panel 
a. Residues in the proximity of the spin label are absent in NMR spectra due to 
paramagnetic relaxation enhancement. EPR acquisition conditions were identical to the 
ones described previously.253  
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Figure 4. Enzymatic cycle279 and conformations of SERCA by ethyl fingerprints. The 
crystal structures are Ca2+-free E2 state (PDB ID: 1IWO), E1-Ca2+ (1SU4), E1-Ca2+-ATP 
(1T5S), and E1-Ca2+∼P∼ADP (2ZBD). Triangle vertices correspond to the centers of 
mass of the three cytoplasmic domains. 
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3.4 Supplemental Data 
 
Figure S1. Synthesis confirmation of ADP-TEMPO, DOPE-TEMPO and 13C EMTS. 
ADPTEMPO was synthesized with the spin label in either 3ʹ or 5ʹ positions, as seen in 
ESI-MS. DOPE-TEMPO spin label was synthesized from DOPE, and the crude product 
(left TLC) was purified by column chromatography, using chloroform:methanol:water 
65:25:4 as eluent. Right TLC shows the increasing concentrations of the purified DOPE-
TEMPO. Ethylating reagent, EMTS, was characterized by 13C solution NMR.  
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Figure S2. ATPase activity assays with varying amounts of 13C EMTS. Molar excess of 
the ethylating reagent over SERCA is indicated in the legend. Out of 24 cysteine residues 
in SERCA1a, 16 are expected to be solvent exposed and accessible for labeling. 
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Figure S3. Identification of the modified peptides in the trypsin digest. Theoretical patterns 
of CAM and EMTS cysteine modifications were calculated using Protein Prospector, and 
the total ion chromatogram was filtered to include the three most intense signals from the 
envelope. The filtered ion chromatograms were used to identify the peaks corresponding 
to the target peptides, and their identities were further confirmed in the second 
fragmentation. 
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Figure S4. Quantification of tryptic digests using synthetic standards. Peptides 
corresponding to the detected fragments were synthesized and modified with either CAM, 
or 12C-EMTS. Standard mixtures were prepared, and the calibration curves were plotted 
using the integrated ion chromatograms. The calibration plot was used to assess the 
relative ratio of CAM and 13C-EMTS in the digests.  
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Figure S5. Evaluation of cysteine labeling in SERCA digests. Each tryptic peptide shown 
was processed according to the procedure exemplified in Figs. S3-4. Cysteines 364, 471, 
498, 561 and 674/675 are the ones primarily labeled with EMTS; 636 is fractionally 
labeled, while 614 is mostly not labeled. Tryptic peptides for cysteines 12 and 52.  
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Figure S6. X-ray structures of SERCA1a. Conformational state and PDB codes are 
indicated. Domains are color coded as follows: A (red), N (green), P (blue), TM (white). 
Similar structures are indicated with rectangles. 
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Figure S7. Distances and angles between the centers of mass of domains A, N and P for 
the structures of SERCA1a shown in Figure S6. The values used to construct the figures 
are tabulated below. 
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Chapter 4 - Probing Residue-Specific Water–Protein Interactions in 
Oriented Lipid Membranes via Solid-State NMR Spectroscopy 
 
 
Reprinted with permission from:  
Alysha Dicke, T. Gopinath, Yingjie Wang, and Gianluigi Veglia. Probing Residue-
Specific Water–Protein Interactions in Oriented Lipid Membranes via Solid-State 
NMR Spectroscopy. J.Phys.Chem. B. 2016; 120(42):10959–10968. Copyright 
(2016) American Chemical Society. 
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Abstract 
Water plays a central role in membrane protein folding and function. It not only catalyzes 
lipid membrane self-assembly but also affects the structural integrity and conformational 
dynamics of membrane proteins. Magic angle spinning (MAS) solid-state NMR (ssNMR) 
is the technique of choice for measuring water accessibility of membrane proteins, 
providing a measure for membrane protein topology and insertion within lipid bilayers. 
However, the sensitivity and resolution of membrane protein samples for MAS 
experiments are often dictated by hydration levels, which affect the structural dynamics of 
membrane proteins. Oriented-sample ssNMR (O-ssNMR) is a complementary technique 
to determine both structure and topology of membrane proteins in liquid crystalline 
bilayers. Recent advancements in O-ssNMR involve the use of oriented bicellar phases 
that have improved both sensitivity and resolution. Importantly, for bicelle formation and 
orientation, lipid bilayers must be well organized and hydrated, resulting in the protein’s 
topology being similar to that found in native membranes. Under these conditions, the 
NMR resonances become relatively narrow, enabling a better separation of 1H–15N dipolar 
couplings and anisotropic 15N chemical shifts with separated local field (SLF) experiments. 
Here, we report a residue-specific water accessibility experiment for a small membrane 
protein, sarcolipin (SLN), embedded in oriented lipid bicelles as probed by new water-
edited SLF (WE-SLF) experiments. We show that SLN’s residues belonging to the 
juxtamembrane region are more exposed to the water–lipid interface than the 
corresponding membrane-embedded residues. The information that can be obtained from 
the WE-SLF experiments can be interpreted using a simple theoretical model based on 
spin-diffusion theory and offers a complete characterization of membrane proteins in 
realistic membrane bilayer systems. 
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4.1 Introduction 
Water–protein interactions play an important role in driving the structural dynamics 
and functional properties of proteins.280-284 Hydration forces mediate protein’s packing via 
hydrogen bond networks and shape the structural integrity.285,286 For membrane proteins, 
water has a dual role: it maintains the functional integrity of the domains that are more 
solvent-exposed (juxtamembrane and globular domains of membrane proteins) and plays 
an essential role in the structure and function of lipid membranes. In fact, in the absence 
of water, lipid membranes would not exist as their basic structural units self-assemble due 
to mainly hydrophobic effects.287 
NMR is the only atomic resolution technique that can be used to study water–
protein interactions in fully hydrated samples. Although NMR cannot visualize bound water 
molecules in active sites like X-ray crystallography, it can determine the relative exposure 
of atomic groups (e.g., backbone amides), monitoring either hydrogen/deuterium 
exchange288 or using tailored pulse sequences.289-292 Recently, these methodologies have 
been extended to magic angle spinning (MAS) solid-state NMR (ssNMR) of biological 
macromolecules.293-295 These studies have demonstrated that the water–protein 
interactions in ssNMR can be probed by 1H–1H polarization transfer via chemical 
exchange, nuclear Overhauser effect (NOE), or dipolar spin diffusion between water and 
the surface of the protein.296 However, high sensitivity and resolution of MAS samples 
often require low levels of hydration297 with high protein:lipid ratios. Ideal hydration levels 
for MAS samples were found to be between 30 and 40%, as determined for the integral 
membrane protein diacylglycerol kinase (DAGK).297 Nonetheless, the critical hydration 
level required for protein function may change from system to system, and low hydration 
  94 
levels are likely to affect both the structural dynamics and function of membrane-
embedded enzymes.287,298 
A synergistic ssNMR approach is oriented-sample ssNMR (O-ssNMR), which 
provides direct topological information of membrane proteins in more realistic membrane 
models.54,58,299 In fact, the formation of lipid phases, either mechanically or magnetically 
oriented, requires high hydration levels to reach liquid crystalline lipid phases.299 These 
systems are suitable for characterizing water–protein interactions under native-like 
conditions.241,300-303 Currently, the water–protein interactions of oriented membrane 
proteins require the comparison of the separated local field (SLF) spectra of protein 
samples reconstituted by using protonated and deuterated buffer conditions.304,305 In this 
approach, the residues exchanging with deuterated water cannot be detected in the SLF 
spectrum and are flagged as water-exposed.304,305 A drawback of this method is the 
preparation of two separate samples and/or the manipulation of the sample to exchange 
proton with deuterium. 
In this work, we propose a spectral-editing technique for oriented membrane 
proteins to map the residue-specific water–protein interactions in oriented samples. We 
designed a water-edited (WE) SLF experiment that enables us to determine residue-
specific exposure of the amide groups in oriented lipid membranes. In principle, this new 
approach can be applied to both mechanically and magnetically aligned samples. 
However, the more favorable spectroscopic properties of lipid bicelles63,306 coupled with 
the sensitivity-enhanced (SE) method149,307 make this approach much more powerful. The 
experiment is designed as a pseudo-three-dimensional (3D) experiment to obtain a protein 
fingerprint (polarity index slant angle wheel)308 as a function of mixing time and determine 
the water exposure for each resolved site. As a benchmark, we used uniformly 15N-labeled 
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sarcolipin (SLN), a single-pass membrane protein, whose structure has been fully 
characterized by solution NMR in micelles141,142 and in lipid membranes using both MAS 
and oriented ssNMR.143,145 SLN represents a prototypical transmembrane domain, with a 
membrane-embedded hydrophobic domain (domain II), a juxtamembrane region (domain 
Ib), and two hydrophilic termini comprising basic and aromatic residues that anchor SLN 
in the lipid membrane. H/D exchange factor measurements309 using solution NMR studies 
indicate that both N- and C-termini and the juxtamembrane region (domain Ib) are water-
exposed, whereas domain II is buried in the membrane bilayer and is virtually inaccessible 
to water. The WE-SLF data agree with the exchange factor data and can be interpreted 
with a simple theoretical model based on spin-diffusion theory310, providing a new, general 
approach to test water accessibility for oriented NMR samples. 
 
4.2 Materials and Methods  
4.2.1 Sample Preparation 
Uniformly 15N-labeled SLN was expressed as a fusion protein with maltose-binding 
protein (MBP) in Escherichia coli, as previously described.311,312 SLN was purified via 
amylose affinity chromatography, and MBP was cleaved using tobacco etch virus 
protease. The cleaved proteins were dialyzed in water, and the SLN precipitate was further 
purified using reverse-phase high-performance liquid chromatography. The purified SLN 
was lyophilized overnight. The lipids, 31 mg deuterated 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) and 6.7 mg deuterated 1,2-dihexanoyl-sn-glycero-3-
phosphocholine (D6PC), were dried and lyophilized overnight. The lyophilized SLN (1.9 
mg) was co-dissolved with the deuterated DMPC using 500 μL of 1:1 ratio of methanol 
and water. The methanol was evaporated under a stream of N2 gas, and the mixture was 
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lyophilized overnight to ensure removal of any remaining trace of organic solvent. The 
SLN/DMPC mixture was resuspended in 70 μL NMR buffer (20 mM N-(2-
hydroxyethyl)piperazine-N′-ethanesulfonic acid, 50 mM KCl, 2.5 mM MgCl2, 0.02% NaN3) 
and sonicated. D6PC dissolved in 50 μL NMR buffer was then added. To prepare bicelles 
that align with the membrane normal parallel to the direction of the static field, YbCl3 was 
added to a final concentration of 5 mM. Bicelles were formed after 3–5 freeze/thaw cycles, 
which resulted in a nonviscous solution between 0 and 15 °C and a viscous and clear 
solution above 30 °C. The final volume was adjusted to 160 μL by addition of NMR buffer, 
giving a final lipid concentration of 28% (w/v). Bicelles were transferred to a flat-bottom 
glass tube (New Era Enterprises) and tightly sealed with a polytetrafluoroethylene cap. 
 
4.2.2 NMR Spectroscopy 
All of the NMR experiments were performed on a Varian NMR System 
spectrometer operating at a 1H frequency of 700 MHz equipped with a low-E bicelle probe 
built by the RF program at the National High Magnetic Field Laboratory in Florida.313 A 90° 
pulse of 5 μs that corresponds to 50 kHz was used for both 15N and 1H channels, and a 
cross-polarization (CP) time of 500 μs was applied at 1H and 15N radio frequency (RF) field 
strengths of ∼50 kHz. For WE experiments, the 𝜏 value was set to 1.8 ms that acts as a 
T2 filter and dephases 1H magnetization of the protein and lipid molecules, while retaining 
the water magnetization. Water–protein polarization transfer was achieved by varying the 
𝜏𝑚𝑖𝑥 value. For heteronuclear correlation (HETCOR) and SE-HETCOR 
experiments,148 the windowless isotropic mixing (WIM) pulse sequence314 was used for 
heteronuclear polarization transfer. During SE-polarization inversion spin exchange at the  
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magic angle (PISEMA),307 the t1 frequency-switched Lee–Goldburg 
(FSLG)315 homonuclear decoupling was applied on the proton channel with a 50 kHz 
effective field,316 whereas phase-switched spinlock pulses on the 15N channel were 
Hartmann–Hahn317 matched with a 50 kHz RF amplitude during t1 evolution. For 
sensitivity enhancement, the 𝜏 delay was set to 75 μs, which corresponds to three cycles 
of FSLG with an effective RF amplitude of 80 kHz. Small phase incremental alteration 64 
(SPINAL64) decoupling was used during acquisition with 50 kHz 1H RF amplitude.318 All 
of the data were processed using NMRPipe199 and analyzed using SPARKY.200  
 
4.2.3 Theory and Analysis of ssNMR Data 
To interpret the spin diffusion in our system, we started from the general treatment 
of the diffusion of z magnetization 𝑀(𝑟, 𝜏𝑚)
310 at time 𝜏𝑚𝑖𝑥  
𝜕𝑀(𝑟,𝜏𝑚𝑖𝑥)
𝜕𝜏𝑚𝑖𝑥
=  ∇⃑⃑ ∙ {𝐷(𝑟)∇⃑⃑𝑀(𝑟, 𝜏𝑚𝑖𝑥)}     (1) 
where 𝐷(𝑟) stands for diffusion coefficients. For a two-phase system, the magnetization 
is initially homogeneously distributed in phase A (water) and zero in phase B (protein). As 
the magnetization transfers from phase A to B, the buildup of exchange intensity IB can be 
simplified as follows 
       
𝐼𝐵(𝜏𝑚𝑖𝑥)
𝐼𝐵(𝜏𝑚𝑖𝑥→∞)
= √
𝐷𝜏𝑚𝑖𝑥
𝜋
1
𝑓𝐴𝑓𝐵
𝑆𝐴𝐵
𝑡𝑜𝑡
𝑉𝑡𝑜𝑡
− 𝑂 (√𝜏𝑚𝑖𝑥
2 )  (2) 
in which fA and fB represent the volume fractions of phases A and B, 
respectively. SABtot denotes the total area of all interfaces between phases A and B, 
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and Vtot stands for the total sample volume. Assuming fA ≈ 1, and neglecting the quadratic 
terms 𝑂 (√𝜏𝑚𝑖𝑥
2 ), we obtain 
     
𝐼𝐵(𝜏𝑚𝑖𝑥)
𝐼𝐵(𝜏𝑚𝑖𝑥→∞)
≈ √
𝐷𝜏𝑚𝑖𝑥
𝜋
𝑆𝐴𝐵
𝑡𝑜𝑡
𝑉𝐵
     (3) 
in which VB denotes the volume of phase B. The magnetization transfer between water 
and a membrane-embedded protein results in a slow spin diffusion at the water–protein 
interface (WP) and a much faster intramolecular spin diffusion within the protein (PP). 
Therefore, we use an effective diffusion coefficient Deff to account for the observed 
magnetization transfer in this more complex system 
  
𝑀𝑃(𝜏𝑚𝑖𝑥)
𝑀𝑃(𝜏𝑚𝑖𝑥→∞)
 ≈ √
𝐷𝑒𝑓𝑓
𝜋
𝑆𝑊𝑃
𝑉𝑃
√𝜏𝑚𝑖𝑥    (4) 
where SWP stands for the total area of the water–protein interface, and VP is the volume of 
protein. For MP(𝜏𝑚𝑖𝑥
s) = MP(𝜏𝑚𝑖𝑥 → ∞), we obtain 
            √𝜏𝑚𝑖𝑥
𝑠 =  √
𝜋
𝐷𝑒𝑓𝑓
𝑉𝑃
𝑆𝑊𝑃
     (5) 
Therefore, the magnetization of each residue along the protein sequence goes to 
saturation with different values of √𝜏𝑚𝑖𝑥
𝑠  depending on their water exposure. Specifically, 
the TM domain of SLN can be approximated as a cylinder of volume VP = πRTM2h, 
where RTM and h are the radius and height of the TM domain, respectively. Therefore, the 
residue-specific √𝜏𝑚𝑖𝑥
𝑠  becomes linearly dependent on the position of each residue with 
respect to the helix 
        √𝜏𝑚𝑖𝑥
𝑠 ~ √
𝜋
𝐷𝑒𝑓𝑓
𝜋𝑅𝑇𝑀
2 ℎ
𝑆𝑊𝑃
    (6) 
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4.3 Results 
The new SLF pulse sequences used to probe the water accessibility for SLN are 
depicted in Figure 1. Figure 1A shows the one-dimensional (1D) WE-CP experiment that 
uses water as a source of polarization for recording 15N signals from SLN’s amide 
backbone. The pulse sequence has an initial water-filter element identical to the MAS 
experiments.293,294,296 An initial 90° pulse is followed by a spin-echo (∼2 ms) that serves 
as a T2 filter to dephase the protein as well as the lipid magnetization. The mobile water 
molecules, with longer T2 relaxation, retain their magnetization, which is then flipped to 
the z-direction by another 90° pulse. A subsequent longitudinal mixing period (𝜏𝑚𝑖𝑥) 
enables the transfer of 1H polarization from water to protein, which is then transferred 
to 15N using a 90° pulse followed by Hartmann–Hahn CP.317 During CP, only the 
immobilized residues are subjected to heteronuclear polarization transfer via dipolar 
couplings. Figure 1B shows the implementation of the T2 water-filter HETCOR 
experiment, WE-HETCOR. In this case, the t1 evolution before 𝜏𝑚𝑖𝑥 encodes the 
1H 
chemical shift of water. After the 1H–1H transfer, the amide proton magnetization is 
selectively transferred to the corresponding amide 15N by the WIM24-CP314 sequence 
followed by t2 acquisition under SPINAL heteronuclear decoupling.318 Figure 1C shows 
the two-dimensional (2D) WESE-PISEMA experiment, where the initial 𝜏 period, preceded 
by a 90° pulse, retains 1H polarization from water, while dephasing the 1H coherences 
arising from the protein and lipids. The protons of the protein are polarized via 
homonuclear zz transfer during the 𝜏𝑚𝑖𝑥 period followed by a SE-PISEMA sequence. 
The application of WE-CP to a U–15N SLN sample reconstituted in lipid bicelles is 
shown in Figure 2A at different 1H–1H mixing times. Overall, the buildup is similar to that 
observed for the MAS experiments, with a sigmoidal trend.293,294,296 At zero mixing time 
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(Fig. 1A), no signal is detected, confirming that the protein magnetization is completely 
dephased due to the initial spin-echo period. At short mixing times, we observe only a few 
selected signals. As the mixing time increases, the intensity of several other peaks builds 
up and reaches saturation at approximately 100 ms (Fig. 2B). A comparison between 2D 
SE-HETCOR and WE-HETCOR experiments is reported in Figure 2C. A 1H–15N 
correlation spectrum obtained with the SE-HETCOR experiment in the absence of the 
T2 filter is shown in red. The spectrum acquired using the WE-HETCOR experiment with 
a 1.8 ms T2 filter and 100 ms mixing time (𝜏𝑚𝑖𝑥) is reported in black. As expected, the 
15N 
resonances of SLN’s backbone are correlated with the water resonance at 4.7 ppm in the 
indirect dimension, whereas no correlations are obtained with amide or lipid protons, 
demonstrating that the T2 filter retains only water magnetization. 
To obtain site-specific water–protein interactions for the U–15N SLN sample in lipid 
bicelles, we incorporated the T2 filter into the SE-PISEMA experiment. SLN is a 31-residue 
helical membrane protein with short N- and C-terminal tails and is anchored to the lipid 
membrane via positively charged arginines.141,143,319 MAS and oriented ssNMR 
experiments carried out in our laboratory have revealed the high-resolution structural 
topology of SLN in lipid bicelles.145 The structure of SLN consists of a regular α-helix, 
flanked by several aromatic amino acids on both the luminal and cytoplasmic sides of the 
membrane bilayer. The SE-PISEMA spectra are well-resolved and enabled residue-
specific assignments using both 2D and 3D experiments.145 Figure 3 shows the SE-
PISEMA and WESE-PISEMA spectra of SLN, where 𝜏𝑚𝑖𝑥 was set to 100 ms for 
1H–1H 
transfer. As expected, at 100 ms mixing time, almost all of the residues are polarized by 
water via the spin-diffusion mechanism. Using a WESE-PISEMA sequence coded as a 
pseudo-3D experiment, we monitored the spin-diffusion kinetics, with 𝜏𝑚𝑖𝑥 values 
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spanning from 1 to 100 ms. Figure 4 shows the resultant spectra at various mixing times. 
At short mixing times, the WESE-PISEMA spectra display very low signal-to-noise ratios. 
For this reason, the 2D spectra with mixing times less than 10 ms were acquired with 512 
scans, whereas 96 scans were sufficient for spectra acquired at longer mixing times (Fig. 
4). For comparison, all of the spectra were plotted at the same noise level, and peaks 
corresponding to a signal-to-noise ratio greater than eight were picked. To interpret the 
spin diffusion of the z magnetization, we utilized the spin-diffusion theory described by 
Schmidt-Rohr and Spiess.310 Assuming a simple geometric model for the single 
transmembrane domain of SLN, we modified the master equation to obtain Equation 
5 (see Theory and Analysis of ssNMR Data). The buildup plots of the intensities of SLN 
residues as a function of the square root of mixing time are shown in Figure 5. Note that 
due to dynamics, both N- and C-terminal residues are not sensitive to CP-based 
experiments and are not visible in the PISEMA spectra.144 As for the integrated 1D 
spectrum of the WE-CP and MAS WE experiments,296 the individual curves follow a 
sigmoidal behavior. The initial rate of polarization, 1–7 ms, is relatively fast for residues in 
domain Ib, including N11, T13, I14, and V15. Based on our model, this depends on the 
fast kinetics of polarization transfer from water to protein. This pattern is in agreement with 
previous solution NMR data carried out on SLN reconstituted in dodecylphosphocholine 
micelles, showing that the juxtamembrane domain Ib of SLN (residues 7–14) is more 
dynamic and has a higher solvent accessibility.142 Note that the CP transfer is also 
influenced by protein dynamics and mosaic spread, as reflected by the nonuniform 
intensities of the peaks.320 Because of its lower sensitivity, N11 could only be detected at 
7 ms mixing time. In addition, residues T13 and L24 are overlapped in the 2D SE-PISEMA 
spectrum. To resolve this ambiguity, we ran a WE-CP experiment on a selectively leucine-
labeled sample using 3 ms mixing time (Fig. 6). None of the leucine peaks were detected 
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in the WE-CP spectrum. The latter confirms that leucine residues in domain II of SLN are 
embedded within the core of the membrane and are not water-accessible. Nonetheless, 
these residues show clear peaks at longer mixing times, showing that spin diffusion is 
dominant and all of the residues can be polarized. On the basis of Equation 6 in the 
previous section, the residue-specific mixing time √𝜏𝑚𝑖𝑥
𝑠  was fitted against the height of 
residue in the TM regions. Overall, we found a linear relationship, where most of the 
residues lie within the 99% confidence intervals, supporting the theoretical model (Fig. 7). 
The small deviations from the theoretical model found for residues L16 and I17 are due to 
the low signal-to-noise ratio that is unavoidable for these sample 
preparations. Figure 8 summarizes the site-specific water accessibility for SLN as 
obtained from the WE experiments. The backbone sites that are dynamic and not visible 
in the WESE-PISEMA spectra are represented in red. The other sites with increasing 
protection from the solvent are reported in yellow, green, cyan, and blue. The presence of 
resonances for the most protected residues in the PISEMA experiments at longer mixing 
times is due to water → protein → protein spin diffusion, which reaches complete 
saturation at mixing times greater than 100 ms. Overall, there is very good agreement 
between the exchange factors measured for SLN by solution NMR in micelles142 and 
WESE-PISEMA spectra in lipid bicelles. 
 
4.4 Discussion 
For soluble proteins, water accessibility provides important insights into structural 
stability and dynamics.321 On the other hand, for membrane proteins, it also provides a 
ruler to establish their insertion and topology within lipid membranes. In spite of the 
significant progress made by hydrogen/deuterium mass spectrometry,322 NMR remains 
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the technique of choice to determine the relative water accessibility of protein residues at 
atomic resolution. Although solution NMR is able to map both kinetics and 
thermodynamics of membrane proteins in micelles, there is mounting evidence that 
micelles do not mimic membrane environments.241,323,324 Both MAS and O-ssNMR utilize 
lipid environments to reconstitute membrane protein samples. Unlike in MAS, the samples 
used in O-ssNMR contain more than 70% water; hence, this method is ideal for probing 
water–protein interactions in a residue-specific manner. In particular, bicelles are 
emerging as a robust membrane-mimetic system for both small and large membrane 
proteins.63,65 The self-assembly of lipid molecules for bicelle formation requires high 
hydration levels to form oriented phases.325 A significant advantage of bicelles is the long 
relaxation in the dipolar dimension of the SLF experiments that enable the implementation 
of sensitivity-enhancement schemes146 and boost the sensitivity of the static NMR 
experiments. The new experiments reported here make it possible to monitor the water 
exposure of amide resonances with relatively high sensitivity. As for the previous MAS 
experiment, water–protein polarization transfer is mediated by chemical exchange, NOE, 
and spin-diffusion mechanisms.281,296 These studies have demonstrated that, although the 
rate of 1H–1H transfer depends on these mechanisms, the shorter mixing times used make 
it possible to select the residues most accessible to water. The behavior of the polarization 
transfer in our static WE experiments follows the same trend and could also be utilized as 
a spectral-editing technique.326,327 From an experimental point of view, a key parameter is 
the mixing time, 𝜏𝑚𝑖𝑥, which needs to be optimized for polarization transfer from water to 
protein. For SLN, we found that even at short mixing times (1–3 ms), the residues of the 
juxtamembrane domain Ib are polarized, indicating the close proximity of water molecules. 
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Although there have been several advancements in the field of O-ssNMR,54 there 
are still limitations for larger membrane proteins that present significant overlap of 
resonances in the SLF experiments. WE experiments under MAS conditions have been 
successfully used for studying G protein-coupled receptor, potassium channel, and M2 
channel membrane proteins,293 but the spectral simplification via the WE experiments 
presented in this article could be a turning point for new methodological developments to 
determine the 3D structure of larger, oriented membrane proteins. 
 
4.5 Conclusions 
We demonstrated the ability of O-ssNMR to investigate residue-specific hydration 
of membrane proteins reconstituted in oriented lipid bicelles. The relative exposure of the 
residues to water provides a ruler to establish the location and the structural topology of 
the transmembrane segments in fully hydrated liquid crystalline membranes. Indeed, 
these results demonstrate that the water molecules are indeed an intrinsic part of the 
membrane protein environment and can be further exploited to study protein function. In 
the case of SLN, the accessibility of the juxtamembrane domain Ib supports the plasticity 
of this protein and the importance of this domain in the regulation of the Ca2+-ATPase, 
supporting previous studies carried out in detergent micelles. Together with the recent 
advancements in sample preparation and NMR methodology, the WE experiments 
presented here will bring a new dimension in O-ssNMR to study membrane proteins. 
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Figure 1. WE-oriented ssNMR. Pulse sequences for (A) WE CP, (B) 2D HETCOR 
experiment for water–protein correlation, and (C) WESE-PISEMA that can be used as 
pseudo-3D by varying the 𝜏𝑚𝑖𝑥 value. 
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Figure 2. (A) WE-CP spectra obtained at various mixing times using the pulse sequence 
of Figure 1A. (B) Integrated intensity of the 1D spectra between 130 and 210 ppm is 
plotted with respect to the square root of mixing time. (C) 2D HETCOR spectrum (black) 
between water and protein residues obtained from the pulse sequence shown in A using 
100 ms mixing time and 1HN–15N correlation (red) of the protein backbone obtained from 
the SE-HETCOR experiment. 
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Figure 3. 2D SE-PISEMA and WESE-PISEMA spectra of uniformly 15N-labeled SLN in 
oriented flipped bicelles. A mixing time of 100 ms was used for WESE-PISEMA. 
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Figure 4. WESE-PISEMA spectra of SLN obtained at various mixing times using the pulse 
sequence of Figure 1C. All of the spectra are plotted at the same noise level. The 𝜏𝑚𝑖𝑥 
values were 1, 3, 5, 7, 9, 10, 50, 70, and 100 ms. The spectra at 𝜏𝑚𝑖𝑥 values less than 10 
ms were acquired with 512 scans. The remaining spectra were acquired with 96 scans. 
For comparison, all of the spectra are plotted using the same noise level. 
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Figure 5. Peak intensities of each residue obtained from Figure 4 plotted with respect to 
the square root of mixing time. The intensity of each peak was normalized relative to its 
SE-PISEMA intensity. The residues near the termini build up faster than those within the 
transmembrane region. The residues with peaks that are overlapped, such as T13, are 
not plotted. 
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Figure 6. CP (top) and WE-CP (bottom) spectra of selectively leucine-labeled SLN. WE-
CP was acquired with a mixing time of 3 ms. No peaks are observed, indicating that L24 
is not accessible to water at 1–3 ms mixing time. 
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Figure 7. Model of residue-specific magnetization transfer from water to SLN. (A) 
Schematic illustration of the membrane protein complex. SLN’s helical structure can be 
approximated as a tilted cylinder with a radius R. The height, h, is the distance of the 
residue in the TM region from the water–protein interface. (B) Linear fitting (red) of the 
residue-specific against h of each residue. The boundary of the 99% confidence intervals 
is shown as blue lines. 
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Figure 8. Water-exposed residues highlighted on the SLN structure obtained from 
molecular dynamics simulations.319 Left: distribution of the water molecules as mapped 
during the molecular dynamics trajectories. Right: structure of SLN in lipid membranes. 
Red indicates residues that are too mobile to be observed in PISEMA but are assumed to 
be water-exposed. Otherwise, the residues are colored according to the mixing time (1–
70 ms) at which the peak has a signal-to-noise ratio of eight or greater. 
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Chapter 5 -  Mapping of SLN Conformational States Along the 
Enzymatic Pathway of SERCA 
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5.1 Introduction 
The sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) is a membrane 
transporter that is an essential component of muscle function. SERCA uses energy from 
ATP hydrolysis to pump two Ca2+ ions from the cytosol of muscle cells into the 
sarcoplasmic reticulum causing muscle relaxation.150,248,328 This process is tightly 
regulated by interactions with peptides encoded by small open reading frames (smORFs) 
including sarcolipin (SLN),116 phospholamban (PLN),119 and the more recently identified 
myoregulin,104 DWORF,105 and sarcolambans (in Drosophila).106 Significantly, mutations 
and abnormal expression of SLN and PLN can lead to pathological conditions in humans 
as they result in poor Ca2+ handling by SERCA,110-114,125 and further research may also 
unveil similar outcomes for the newly identified regulators of SERCA.  
 Given the potential pathological impact of Ca2+ mishandling, understanding how 
these peptides interact with and regulate SERCA is important; especially crucial is 
discerning how their structural differences lead to disparate effects on SERCA’s activity. 
Both SLN and PLN inhibit SERCA, decreasing its apparent calcium affinity119,120,329,330 and 
bind within the groove formed by TM helices M2, M4, M6, and M9 of SERCA.123,158,159,331-
333 However, SLN, but not PLN, also uncouples SERCA’s Ca2+ transport and ATP 
hydrolysis activities.121-123 These functional differences between SLN and PLN have 
physiological relevance. PLN is primarily expressed in cardiac muscle119 and regulates 
SERCA2a.101,102 Phosphorylation of PLN by protein kinase A (PKA) through the β-
adrenergic response relieves inhibition, allowing SERCA to pump more Ca2+ enhancing 
cardiac relaxation.113,330 SLN on the other hand is expressed in skeletal muscle and in the 
heart atria.109,117,118 SLN regulates both SERCA1a and SERCA2a, as SERCA1a is 
expressed in fast-twitch skeletal muscle99,100 and SERCA2a in cardiac and slow-twitch 
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skeletal muscle.101,102 Compared to PLN, less is known about SLN’s role in modulating 
cardiac function, but cardiac relaxation is impaired by SLN overexpression in atria and 
improved in SLN-knockout mice.124-126 Likewise, although inhibition of SERCA by SLN can 
also be reversed through phosphorylation, the physiological role for this is much less clear 
than for PLN, however, it is known that preventing phosphorylation at Thr-5 of SLN by 
CaMKII in cardiac muscle can have adverse effects in mice and rats.124-126 In skeletal 
muscle, SLN’s uncoupling of SERCA’s Ca2+ transport and ATPase activities leads to 
increased heat production,121,122 which may play a key role in muscle-based 
thermogenesis as well as compensating for metabolic overload.123,127,334  
SLN and PLN are functionally distinct, and while they are structurally similar in 
many ways, they accordingly have key structural differences.123,335-337 Both peptides 
consist of a single-pass transmembrane helix with two domains, one of which is more 
hydrophilic.142,338,339 The transmembrane helix of PLN crosses the bilayer with a tilt angle 
of ~15–20°,256,340,341 while SLN has a tilt angle of ~24°.144,145 Significantly, PLN is larger at 
52 amino acids compared to SLN’s 31 amino acids.120 Their difference in length is largely 
due to PLN’s cytoplasmic helix, whereas SLN has a much shorter cytosolic region that is 
unstructured.142,341-343 PLN’s conformational equilibrium and cytoplasmic domain play a 
key role in regulating SERCA. There are three main states of PLN: a ground state (T 
state), an excited state (R state), and a SERCA-bound state (B state).253,332,333,344 In the T 
state, the cytoplasmic domain is bound to the lipid membrane, but in the R state, the 
cytoplasmic domain is detached from the membrane and unfolded. Both states inhibit 
SERCA. In the B state, the cytoplasmic domain is bound to SERCA, and PLN is no longer 
inhibitory. Phosphorylation of PLN at Ser-16 by PKA shifts the equilibrium to the B state 
reversing inhibition.345 SLN is phosphorylated at Thr-5, but there is no model equivalent to 
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that of PLN that describes the structural effects of phosphorylation on SLN. Recent studies 
have suggested that the N-terminus of SLN, where Thr-5 is located, interacts with SERCA 
to cause uncoupling,164,165 but more information is needed to verify how/if the N-terminus 
is involved in uncoupling for all species of SLN (this region is not highly conserved120). 
However, SLN does have a highly-conserved C-terminus/luminal tail that is critical for 
inhibiting SERCA’s activity.120  Overall, it is at least clear that the mechanisms of how SLN 
and PLN modify SERCA have distinctions. 
Studies of SERCA by itself have led to a structural understanding of the changes 
SERCA undergoes during Ca2+ transport, as it has been crystallized at several different 
stages of the transport cycle.150,259,261,346-348 And while there are several hypotheses as to 
how the interactions of SERCA with regulatory peptides affect SERCA’s 
activity,120,158,159,165,349 a detailed description of the molecular mechanism of action remains 
elusive. Here, preliminary data on the effects of phosphorylated SLN on SERCA’s activity 
suggest that the N-terminus may have a role in modulating uncoupling. Furthermore, the 
structure of SLN bound to SERCA in different conformations has been further 
characterized using solid-state NMR spectroscopy (ssNMR) to enhance our 
understanding of the molecular mechanism of regulation.  
 
5.2 Materials and Methods 
5.2.1 Protein Preparation 
Unlabeled, uniformly15N-labeled, and uniformly 13C, 15N-labeled human sarcolipin 
were purified from E. coli using methods described previously.311,312 For selectively-
labeled samples, the ML12 auxotrophic strain was utilized,350 and SLN was expressed in 
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minimal media containing 100 mg/L of the desired unlabeled or isotopically-labeled amino 
acid(s) (leucine, valine, isoleucine, and tyrosine). SERCA1a from rabbit hind-leg muscle 
was purified into C12E8 detergent using reactive red affinity chromatography also as 
described previously.250 Phosphorylated human SLN was synthesized using a microwave 
synthesizer (CEM Corporation). Phosphothreonine [Fmoc-Thr(PO(OBzl)OH)-OH (Merck, 
Darmstadt, Germany)] was coupled at 50 °C; subsequent deprotection steps were 
performed at room temperature and amino acids 1–4 were coupled at 50 °C to reduce the 
risk of dephosphorylation. The peptide was purified using reverse-phase HPLC similar to 
the recombinant SLN. 
 
5.2.2 ATP Hydrolysis Assays 
Reconstitution of SERCA with and without SLN as well as the coupled enzyme 
assays were completed following well-established protocols.44,120,351-357 To reconstitute 
SERCA and SLN for use in the assays, 200 µg lipids (4:1 DOPC:DOPE) in chloroform 
were dried-down under N2. The lipids were re-suspended with 1.3:1 (w/w) octaethylene 
glycol monododecyl ether (C12E8), 25 mM imidazole, 100 mM KCl, 5 mM MgCl2, and 10 
% glycerol. As needed, 14 µg SLN or phosphorylated SLN (pSLN) solubilized in C12E8 
were added. Once the lipids were fully dissolved, 40 µg of SERCA in 0.1% (w/v) C12E8 
was added. The samples were incubated with 70:1 w/w Biobeads SM2 (Bio-Rad, Cat. No. 
152-3920) to C12E8 for 3 h at room temperature with gentle stirring to remove the 
detergent.   
The ATPase activity of SERCA was measured by a coupled enzyme assay44,351 
that monitored the decrease in absorbance of NADH at 340 nm using a Spectramax plate 
  118 
reader (Molecular Devices). For each well, 0.56 µg of the reconstituted SERCA with and 
without SLN or pSLN was used. For the assays where the crude SR was used in place of 
the reconstituted system, there was approximately 0.13 µg SERCA per well. The activity 
was measured as a function of calcium concentration at 37 °C. The assays with SR were 
also performed as a function of magnesium concentration. The assays were performed in 
triplicate and averaged. Data were fit to the Hill equation to obtain the Vmax and KpCa. 
 
5.2.3 In vitro phosphorylation of SLN 
 Aliquots of 4 µg of SLN in methanol were dried down under a stream of N2. The 
SLN was resuspended in kinase reaction buffer containing 2 mM DTT, 5 mM MgCl2, 2 mM 
ATP, 40 mM HEPES, pH 7.5 and either 3% (w/v) C12E8, 2 mM DPC (n-
dodecylphosphocholine), 1% (w/v) OG (n-octyl-β-D-glucopyranoside), 1% (w/v) DDM (n-
dodecyl-β-D-maltoside), or 0.5% (w/v) OG. To initiate the phosphorylation reaction, 0.8 µL 
CaMKII was added. The reaction was incubated overnight at 33 °C. SDS-PAGE was 
performed with 2 µg of SLN from each reaction followed by a Western blot transfer. 
Phosphorylation was detected with an anti-phosphothreonine antibody.  
 
5.2.4 MAS ssNMR Sample Preparation 
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL). SLN alone 
samples were prepared by co-dissolving 1.2 mg uniformly 13C,15N-labeled SLN in 
methanol with 14 mg deuterated DMPC lipids. The methanol was evaporated off under a 
stream of N2, and the dried down lipids and SLN were lyophilized overnight. The lipids and 
SLN were resuspended in 1 mL of MAS Buffer (20 mM HEPES, pH 7.0, 10 mM KCl, 2.5 
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mM MgCl2, and 2.5% glycerol). The resuspension was centrifuged for 16 hrs at 4 °C and 
70,000xg. The pellet was transferred to a MAS rotor.  
 For the samples with SERCA, 0.35 mg uniformly 13C,15N-labeled SLN in methanol 
was dissolved with 14 mg deuterated DMPC lipids. Again, the methanol was evaporated 
off under a stream of N2, and the dried down lipids and SLN were lyophilized overnight. 
The lipids/SLN were re-solubilized with C12E8 and added to 8 mg SERCA in MAS Buffer. 
Bio-beads at a ratio of 30:1 with the detergent were added, and the solution was stirred 
gently at room temperature for 3 hours. The solution was placed on ice, removed from the 
Bio-beads, and centrifuged at 30,000 RPM at 4 °C for 1 hour. The pellet was resuspended 
in 1 mL of MAS Buffer with 2 mM EGTA and 2 mM AMPPCP or 2 mM CaCl2 and 2 mM 
AMPPCP to promote the E2-AMPPCP and E1-AMPPCP states of SERCA, respectively. 
The vesicles were then centrifuged for 16 hrs at 4 °C at 70,000xg. The pellet was 
transferred to a MAS rotor. 
 
5.2.5 Oriented Sample Preparation (Bicelles) 
 SERCA (8 mg) was dialyzed two times into 2x O-ssNMR buffer (20 mM HEPES, 
50 mM KCl, 2.5 mM MgCl2, 2.5%glycerol, and 0.02% NaN3) with 200 µM EGTA to remove 
any Ca2+ still present after purification. Uniformly- or selectively-labeled 15N SLN (0.25 
mg/sample) was co-dissolved in MeOH with the lipids, 38.6 mg DMPC/POPC/DMPE-
PEG2000 (4:1:0.01 molar ratio), and lyophilized overnight. The lipids/SLN were re-
solubilized with C12E8 and added to SERCA in O-ssNMR Buffer. Bio-beads (30:1 ratio with 
detergent) were added and the solution was stirred gently at room temperature for 3 hours. 
The solution was placed on ice and removed from the Bio-beads via aspiration. The 
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solution was centrifuged at 50,000xg at 4 ˚C for 2 hours to pellet the vesicles. The vesicles 
were re-suspended with ~300 µL of buffer. Once the solution was homogeneously re-
suspended, 6.1 mg of D6PC dissolved in 50 µL of O-ssNMR Buffer was added and mixed 
thoroughly. The sample was then concentrated to 160 µL using a 0.5 mL 10 kDa cutoff 
concentrator at 4ºC. Any compounds to modify the concentration of SERCA were added 
when the solution was ~400 µL This includes 2 mM EGTA, 2 mM CaCl2, and 2 mM 
AMPPCP. The sample was transferred to a flat-bottom glass tube (New Era Enterprises) 
and tightly sealed with a polytetrafluoroethylene cap. 
 
5.2.5 NMR spectroscopy 
 All the O-ssNMR NMR experiments were performed on a Varian VNMRS 
spectrometer with an 1H operating frequency of 700 MHz. The spectrometer was equipped 
with a low-E bicelle probe built by the RF program at the National High Magnetic Field 
Laboratory (NHMFL) in Florida.313 All spectra were acquired at 25 °C following previous 
parameters used for PISEMA experiments of SLN in DMPC-POPC-DHPC bicelles.144 The 
MAS ssNMR data were acquired on a 600 MHz Varian spectrometer with a 3.2 mm 
BioMAS™ probe (Agilent Technologies) at a spinning speed of 12.0 kHz and a 
temperature of 2 °C, unless otherwise mentioned in figure captions. DARR and NCA 
spectra were acquired using a dual acquisition pulse sequence as previously 
described.145,358  All of the NMR data were processed using NMRPipe199 and analyzed 
using SPARKY.200  
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5.3 Results and Discussion 
Phosphorylated SLN 
We assessed whether CaMKII can phosphorylate human SLN in order to use the 
pSLN in further structural studies. To this end, SLN was incubated in kinase reaction buffer 
with ATP and CaMKII, and phosphorylation was detected with an anti-phosphothreonine 
antibody. The presence of bands in the lanes with CaMKII and SLN in Figure 1 
demonstrated that human SLN was phosphorylated by CaMKII, which is in agreement 
with a previous study.124 Given that there is only one threonine in the N-terminus, 
phosphorylation was likely at Thr-5 (there are two other threonines, Thr-13 and Thr-18, 
but they are embedded within the membrane). Additionally, the extent of phosphorylation 
of SLN was dependent on the type of detergent used for solubilization, which highlights 
the importance of the specific type of membrane mimetic used to study membrane 
proteins. SLN in C12E8 displayed the highest level of phosphorylation based on signal 
intensity (all the reaction lanes were loaded with the same amount of SLN). Detergents 
can affect the structure of proteins, so it may be that Thr-5 is more accessible to CaMKII 
in C12E8 compared to the other detergents. In fact, previous NMR studies have shown that 
the unstructured length of the N-terminus varies depending on the detergent/lipid.141,142,145 
This experiment could have also been affected by the solubility of SLN in the detergents, 
but the samples were clear prior to initiating the kinase reaction and SLN does not dissolve 
readily in C12E8 suggesting another factor is the cause for the detergent-dependent 
phosphorylation. The low levels of phosphorylation could also be due to inhibition of 
CaMKII by certain detergents rather than the accessibility of SLN’s N-terminus, but PLN 
in OG is readily phosphorylated by CaMKII whereas SLN in OG is not (Fig. 1). It would be 
interesting to see if using lipids could increase the level of phosphorylation enough to be 
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amenable to studying pSLN via NMR, which would be a step forward in determining the 
mechanism of pSLN’s effect on SERCA. 
Several studies do agree that Thr-5 is the site of phosphorylation.124-126 (This 
distinction was more important for these studies as they used mouse and rabbit 
sequences of SLN, so Ser-4 was a potential site of phosphorylation.124-126 In the human 
sequence, this residue is an asparagine.) However, both CaMKII and STK16 have been 
proposed as the responsible kinase based on 1) in vitro assays showing that CaMKII 
phosphorylated SLN124 or 2) changes in the Ca2+ uptake of microsomes co-expressing 
SERCA and NF-SLN (tagged with a FLAG epitope at the N-terminus) with and without 
STK16.359 This data provides further evidence that CaMKII can phosphorylate SLN, but 
the physiological mechanism and potential role of STK16 remains unclear. 
To further investigate the potential role of SLN phosphorylation, the effects of 
synthetic pSLN on the ATP hydrolysis activity of SERCA were observed and compared to 
unphosphorylated SLN for the first time (Fig. 2). In vitro assays with the proteins 
reconstituted in lipids were performed with and without the calcium ionophore, A23187. 
The presence of the ionophore prevents the formation of a Ca2+ gradient across the vesicle 
membrane, which can cause back inhibition of SERCA. When there was no Ca2+ gradient 
present, pSLN did not alter SERCA’s apparent calcium affinity (KpCa) compared to SERCA 
by itself, whereas unphosphorylated SLN decreased the apparent calcium affinity (Fig. 
2B). Thus, it appears that pSLN does not inhibit SERCA like SLN. SERCA’s Vmax was 
slightly affected by SLN compared to SERCA alone, but phosphorylation of SLN did not 
affect the Vmax relative to SLN (Fig. 2C). Interestingly, in the absence of the ionophore (i.e. 
a Ca2+ gradient was present, which better mimics physiological conditions), SLN still 
decreased SERCA’s apparent Ca2+-affinity, but this apparent affinity was only partially 
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restored by phosphorylation (Fig. 2B). However, pSLN did restore the Vmax to SERCA-
alone levels whereas SLN actually increased SERCA’s Vmax (Fig. 2C).  
Thus far, studies investigating pSLN have mostly tested the effects of SLN 
phosphorylation via monitoring the cardiac myocyte contractility, which is several 
functional steps beyond the biochemical reaction performed by SERCA,124,359 but one 
study did observe changes in Ca2+ uptake for microsomes isolated from HEK-293 cells.359 
Their data also showed a decrease in the KpCa with SLN compared to SERCA alone, and 
that expressing STK16 with SLN and SERCA (presuming that STK16 phosphorylated 
SLN) reversed the inhibition by SLN. Even though the data presented here show only 
partial restoration of the apparent calcium affinity by pSLN when a Ca2+ gradient is 
present, the overall effects are consistent despite the differences in the assays used. The 
microsome-based assay by Gramolini et al.359 measured the Ca2+ uptake whereas the 
assays here measured ATP hydrolysis. Significantly, the change in the apparent calcium 
affinity (ΔKpCa) due to SLN as measured by other ATP hydrolysis assays is similar to the 
change observed here (~0.2 pCa units),120,142,312,360,361 whereas previously reported Ca2+ 
uptake assays are not as consistent with the ΔKpCa ranging from -0.15 to about -0.4 pCa 
units.119,359 The decrease observed here in SERCA’s apparent calcium affinity combined 
with the increase of the Vmax in the presence of SLN and a Ca2+ gradient is suggestive of 
SLN’s uncoupling of SERCA’s Ca2+ transport and ATP hydrolysis activities. These 
preliminary data suggest that pSLN only partially restores the apparent calcium affinity 
while bringing the Vmax back to SERCA alone levels and indicate that phosphorylation of 
Thr-5 in SLN could have a role in modulating the uncoupling of Ca2 transport and ATP 
hydrolysis in SERCA, but further studies are needed to validate these findings.  
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The effects of Mg2+ on SERCA’s activity 
In addition to studying the role of phosphorylation of SLN on SERCA’s activity, the 
effect of Mg2+ was also studied. Both of the crystal structures of SLN in complex with 
SERCA were crystallized under high levels of Mg2+ at ~75 mM and 40 mM Mg2+ (PDB IDs: 
3W5A and 4H1W, respectively),158,159 which are much higher than the estimated 
physiological concentration of Mg2+ of ~1 mM in cardiac myocytes.362 To examine whether 
SERCA is functional under those high Mg2+ conditions, the ATP hydrolysis of purified 
crude SR from rabbit was measured under several concentrations of Mg2+ using the same 
coupled enzyme assay as the reconstituted system. As Figure 3 demonstrates, SERCA 
is essentially fully inhibited under the concentrations of Mg2+ used to crystallize the 
complex. Consistent with this observation, inhibition of SERCA by Mg2+ was reported 
previously with assays that measured Ca2+ uptake under concentrations of up to 10 mM 
free Mg2+.363,364 Inhibition of SERCA by high levels of Mg2+ is not surprising, as it was 
already known that Mg2 can interact with the Ca2+ binding sites365 but is not transported.366 
In fact, both of the published X-ray structures have Mg2+ bound in the Ca2+ binding sites 
of the transmembrane region. This raises questions as to how much these structures can 
tell us about the physiological mechanism of Ca2+ transport and inhibition by SLN. Both 
structures are interpreted as representing intermediates more similar to the 2Ca2+-E1 state 
than the E2 state.158,159,161 Molecular dynamics studies support that this is not likely to be 
a state that is populated under physiological conditions.349 Lastly, neither of these crystal 
structures had strong electron density for the terminal regions of SLN,158,159 which do play 
a role in regulation and/or inhibition of SERCA.120,124,126 Overall the finding that high 
concentrations of Mg2+ inhibit SERCA strongly suggest that more structural/activity studies 
are required on samples prepared under physiological conditions. In this regard, ssNMR 
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should be well-suited to these goals, as the samples can be prepared in a manner that 
maintains the proteins in environments that are more similar to physiological conditions, 
and these conditions can be dynamically altered to induce different states of SERCA and 
test the various structural models for those states. 
 
MAS Sample Comparisons 
 MAS samples of SLN alone as well as the SLN+SERCA complex were prepared 
under conditions different than previously-published SLN alone samples in effort to 
overcome the limitations of previous sample preparations. As such, an understanding of 
the differences between both the SLN alone sample described here and the previously-
published SLN alone sample145 is needed to assess the resulting spectra. The SLN alone 
MAS sample described here included glycerol in the buffer as it is used to help stabilize 
SERCA in the complex samples, whereas the previous sample did not contain glycerol.145 
This sample was also pelleted at a much lower centrifuge speed than the previous sample. 
Significantly, there were clear differences in the SLN alone spectra from these two 
methods as shown in Figure 4. Several possible factors could contribute to the differences 
in peak appearance, but comparison of the DARR spectra for these samples (Fig. 5) does 
not indicate that the difference is likely due to aggregation as the linewidths for the 
hydrophobic residues are similar (Fig. 5), and aggregation would cause the lines to 
broaden. Furthermore, the peaks corresponding to isoleucines, leucines, and valines 
overlay well indicating that SLN is still in an α-helical conformation and not misfolded, as 
the peaks would then shift substantially. It should be noted that some peaks (e.g. Glu-7, 
Phe-9, Phe-12) were not visible in the DARR spectrum from the SLN alone sample 
prepared here compared to the published sample.145 Many factors can alter the exact 
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appearance of the final spectra in this type of experiment. It has been an observed in the 
lab that even the spinning speed and duration of pelleting the sample can significantly 
affect the spectra. A hypothesis for this observation is that the amount of water (and thus 
level of hydration) in the sample will decrease as the pellet is more tightly packed when 
centrifuged longer or at a higher speed, and the degree of hydration will influence these 
types of spectra.297 There is also evidence that the glycerol content can affect spectra 
probably due to changes in the sample viscosity,367 but this may not account for the 
differences here as increased viscosity should lead to broader lines. Interestingly, the 
peaks that were not observed in the DARR spectra presented here are part of the same 
region of SLN (near the N-terminus of the TM region or domain Ib), which is known to be 
more dynamic than the rest of the TM region,71,142 so it may be that differences in hydration 
have altered the dynamics of this region compared to the previous sample, decreasing the 
efficiency of the cross-polarization. Clearly, further studies should be completed to 
elucidate the reasons for these differences.  
Like the SLN alone sample, the SLN+SERCA complex samples may also have 
more conformational heterogeneity compared to the previously-published SLN alone 
sample.145 The NCA spectra for these samples are more similar to each other (Fig. 6) than 
to the published SLN alone NCA spectrum. Furthermore, the peaks in these NCA spectra 
shifted between the SLN alone spectrum and both of the SLN+SERCA (E1-AMPPCP and 
E2-AMPPCP) spectra, which was expected as each of these samples are different. 
However, it is not possible to make assignments as they are not similar enough to the 
previously assigned spectra. Importantly, the DARR spectra (Fig. 7) for these samples do 
not indicate that aggregation is an issue for the SLN+SERCA samples either as they have 
similar linewidths to the SLN alone sample. Significantly, both of these spectra had 
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reasonable signal intensity compared to the SLN alone spectra when accounting for the 
decreased quantity of labeled SLN in the complex samples. Thus, although the NCA 
spectra indicated there was conformational heterogeneity in these samples, it may be that 
this is a current limitation of preparing samples with SERCA.  
 
Structural Studies of the SLN and SERCA Complex 
While more studies are required to reconcile the differences in the MAS data as 
already discussed, the preliminary findings from the other spectra acquired with these 
samples still indicated several interesting points about the SLN+SERCA complex. SLN 
has historically been assumed to behave the same as PLN, so when cross-linking data 
with PLN suggested that elevated Ca2+ levels (16 µM or less) caused PLN to dissociate 
from SERCA,332,368,369 a model was proposed in which both PLN and SLN dissociate from 
SERCA when Ca2+ binds causing the relief of inhibition.368 A former student in the lab 
hypothesized that Ca2+ binding to SERCA instead caused structural changes that affected 
the efficiency of cross-linking at the specific sites previously used.370 As such, 
collaborators in the Periasamy lab monitored cross-linking between two alternate sites in 
SLN: L8C-SLN to W932C-SERCA and S936C-SERCA (Periasamy lab, data not shown). 
The cross-linking efficiency was not only immune to high Ca2+ concentrations (100 µM), 
but even showed a small increase. A later paper from the Periasamy lab showed that other 
sites in SLN cross-link to SERCA more efficiently compared to PLN at high Ca2+ 
concentrations (100 µM) as well.123 One caveat from the studies by the Periasamy lab is 
that all of their experiments utilized the mouse SLN, and assay data has indicated that 
there are functional differences between the human and mouse SLN.120,123,142,164,312,360,361 
As such, we sought to determine whether human SLN is bound to E1-AMPPCP SERCA 
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under our ssNMR sample conditions. The signal intensity for the experiment in Figure 8 
is dependent upon the dynamics of the protein, which should be different for SLN alone 
(3.8 kDa) compared to SLN bound to the 110 kDa SERCA. The intensity of the signal for 
the SLN alone sample changed between 2 °C and 25 °C, but the intensity did not change 
when SERCA with Ca2+ and AMPPCP was present (Fig. 8). Thus, the dynamics of SLN 
have changed in the presence of SERCA, which suggests that even with Ca2+ and 
nucleotide present, SLN still binds to SERCA rather than dissociating. It should be noted 
that this is not the ideal method to observe binding as other factors could be influencing 
the signal intensity; the viscosity and hydration of the sample with SERCA were both likely 
very different than the SLN alone sample (an additional 8 mg of protein were packed into 
the 30 µL sample), and these are both factors that could also affect the dynamics. A gel 
shift assay was attempted under the conditions used in the ssNMR sample, but the amount 
of lipids caused too much smearing. While there is not yet a definitive answer for whether 
human SLN binds to SERCA with Ca2+ present, these data are congruent with the model 
that SLN behaves more like a subunit of SERCA and that relief of inhibition is not due to 
dissociation upon Ca2+ binding.  
Preliminary INEPT data, which provides information about mobile residues, was 
also acquired for these MAS samples. Overlaying the SLN alone sample here with the 
previously published data145 further indicated that aggregation was not an issue as the 
spectra overlaid well (Fig. 9). For the SLN alone spectra, the residues of SLN’s N- and C- 
termini are observed (Figs. 9 and 10). When SERCA is present in either the E2-AMPPCP 
or E1-AMPPCP states, the peaks corresponding to the C-terminal/luminal tail residues, 
e.g. Tyr-31 and Glu-30, decrease in intensity indicating that they have become 
immobilized and are likely bound to SERCA (Fig. 10). However, the N-terminal residues 
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are still observed, and thus do not seem to interact strongly with SERCA in these states. 
A previous study observed that the luminal tail is immobilized when SLN is bound to 
SERCA,163 and another study’s assay and mutagenesis data found that the luminal tail 
was critical to SLN’s inhibition of SERCA, which led to their conjecture that it binds to the 
loop between M1 and M2 of SERCA.120 These interactions would lead to inhibition through 
limiting the motion of these helices, which undergo significant structural rearrangements 
during Ca2+ transport. Both of those studies are consistent with the interpretation of the 
INEPT spectra shown here in Fig. 10, however other recent studies have suggested that 
the N-terminus of SLN also interacts with SERCA to cause uncoupling,164,165 which is not 
consistent with the data presented here as these residues are still visible in the INEPT 
spectra. While these INEPT experiments should be repeated and verified, there are 
factors that could account for this discrepancy. The studies that found interactions 
between the N-terminus and SERCA did not use human SLN, but rabbit165 and mouse164 
SLN, which have key differences (Fig. 11). Significantly, both studies found important salt 
bridges between Glu-2 of SLN with Arg-324 of SERCA164 or Arg-324 and Lys-328.165 The 
study by the Periasamy lab also found a salt-bridge between Arg-3 of SLN and Glu-34 of 
SERCA.164 However, in human SLN the amino acids at positions 2 and 3 are glycine and 
isoleucine, respectively (Fig. 11); neither of these residues would form a salt-bridge. 
Further indication that there may be important differences in SLN depending on these 
sequence differences is that the biochemical assay data are also not consistent between 
human and other species’ SLN. In our data, we see a decrease of ~0.2 pCa units in 
SERCA’s apparent calcium affinity (Fig. 2), which agrees with several other studies that 
measured ATP hydrolysis in the presence of human SLN by other labs.120,142,312,360,361 
However, the Periasamy lab sees no change in the apparent calcium affinity of SERCA 
compared to mouse SLN and SERCA.123,164 In addition to using mouse SLN rather than 
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human SLN, the Periasamy lab also uses microsomes from HEK293 cells instead of fully 
reconstituting the proteins, and they measure ATP hydrolysis with the Biomol green 
reagent whereas many of the other studies used the NADH-based coupled-enzyme assay 
as we do.120,123,142,164,312,360,361 A significant difference between the NADH-based coupled-
enzyme assay and the Biomol green method is that ATP is not regenerated in the Biomol 
green assay, and ADP is known to have a regulatory effect on SERCA,371 therefore its 
accumulation could affect activity. Lastly, mutagenesis experiments demonstrate that the 
luminal tail is critical for SLN’s inhibition of SERCA,120 and it is highly conserved (with 
100% identity) among mammals whereas the N-terminus is much more variable (see Fig. 
11 and ref. 120), so it seems highly likely the luminal tail would have the more important 
role in the fundamental mammalian processes of uncoupling and heat production. Overall, 
the role each terminus plays in how SLN affects SERCA is still not fully clear and more 
detailed studies need to be completed to elucidate the mechanism of uncoupling, 
however, the data presented here are consistent with the model that the luminal tail is key 
for this process.   
In addition to using MAS ssNMR to investigate the SLN+SERCA complex, O-
ssNMR was also used to monitor the topology of SLN bound to SERCA under different 
conditions. With the PISEMA experiment, both the tilt and rotation angle of SLN in bicelles 
can be determined. Previously, the high-resolution structure of SLN in lipid bilayers using 
O-ssNMR was calculated to have a tilt angle of 24˚±1˚ with respect to the membrane 
normal and a rotation angle of 57°± 5°.145 This topology is conserved with different 
membrane mimetic systems144 as well as the presence of nucleotide or Ca2+.370 This is 
likely due to stringent restrictions placed on the tilt and rotation angle by the interfacial 
residues W23, R27, and R6.144,145 Here, uniformly 15N-labeled SLN was reconstituted with 
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SERCA in bicelles with EGTA and AMPPCP to mimic the E2-ATP state of SERCA, and 
then Ca2+ was added to induce the E1-ATP state of SERCA (Fig. 12). The tilt and rotation 
of SLN are similar in presence of both states of SERCA; however, there are clear changes 
between the spectra. To assess these changes, we used selectively-labeled samples to 
be able to assign the PISA wheel for the SLN+SERCA complex. Three main labeling 
schemes were used: 1) 15N-labeled leucines 2) 15N-labeled isoleucines and 3) all residues 
were 15N-labeled except leucines, isoleucines, and valines. Spectra from these selectively-
labeled samples were compared to the uniformly 15N-labeled SLN alone spectrum (Fig. 
13) prior to being used to make samples with SERCA and matched the previous 
assignments. These labeled SLN peptides were then used for complex samples prepared 
the same way as the uniformly 15N-labeled SLN complex sample, in which 1) EGTA and 
AMPPCP were added to the bicelle, and 2) the PISEMA spectrum acquired, then 3) CaCl2 
was added, and 4) the spectrum was re-acquired. These samples helped identify changes 
that would not have been observed easily otherwise. For example, in the 15N-leucine 
labeled sample, an extra peak was observed upon the addition of CaCl2 (Fig. 14A), which 
is likely L10 based on both a previous assignment147 and on the periodicity of the PISA 
wheel (the only other leucine is Leu-8, which would appear on the opposite side of the 
wheel). This indicates that the N-terminus of the TM region of SLN becomes more helical 
when Ca2+ binds to SERCA. As Figure 14B shows, with the 15N-Ile-labeled SLN+SERCA 
samples, no extra peaks were observed, but there were slight changes in the spectra.  
The selectively-labeled samples allowed us to make estimated assignments of the 
uniformly 15N-labeled SLN+SERCA samples (Fig. 15, see also Table 1). While these 
assignments cover most of the TM region of SLN and therefore, the PISA wheel, some of 
the peaks outside the wheel (110-125 ppm and ~0.8 kHz) show the most significant 
changes (Fig. 15). These were not able to be assigned using the labeling schemes 
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described here, but future studies should use other labeling schemes to assign these 
residues, as they may help to further elucidate how SLN interacts differently with SERCA 
(with AMPPCP bound) depending on whether Ca2+ is also bound or not.  
Unfortunately, these data cannot tell us about the changes in SERCA’s structure 
due to SLN binding or how SERCA changes with and without Ca2+ with SLN bound. 
Structural studies of SERCA reveal that when SERCA transitions from the E2 to E1 states, 
the groove formed by M2, M4, M6, and M9 collapses due to the movements of M1 and 
M2.150 This observation contributed to the hypothesis that PLN and SLN dissociate from 
SERCA when Ca2+ is bound, but the MAS and O-ssNMR data presented here as well as 
other published data123 indicate that SLN does not dissociate from SERCA when Ca2+ 
binds. Furthermore, structural transitions in the TM region must occur for SERCA to 
transport Ca2+ from the cytosol to the lumen. As SLN remains bound to SERCA123  and 
seems to maintain the same tilt and rotation angles whether Ca2+ is bound to SERCA or 
not (Fig. 15), the interactions of SERCA’s TMs 2,4,6 and 9 with SLN must change in some 
manner. Indeed, the change in the efficiency at different cross-linking sites due to the 
presence of Ca2+ (Periasamy lab, data not shown) supports that SLN’s interactions with 
SERCA are different with and without Ca2+. Some studies have suggested that SLN 
stabilizes an E2 state of SERCA120 whereas other studies suggest that SLN stabilizes an 
E1 state.158,159,165 As such, it seems reasonable to propose that SLN forms a wedge that 
interferes with the movement of M1 and M2 contributing to the decrease in SERCA’s 
apparent calcium affinity (Fig. 16). Further studies investigating the changes in the 
interactions between SLN and SERCA in different states, including molecular dynamics 
simulations with experimental data from ssNMR, may help illuminate some of the 
remaining questions.  
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Additionally, the roles of the termini and the mechanism of uncoupling are still 
unclear. Normally, after nucleotide and Ca2+ binding to SERCA, the phosphoryl transfer 
causes changes in the cytoplasmic domains, which are connected to conformational 
changes in the TM region leading to Ca2+ occlusion.150,348 This results in the tight coupling 
between ATP hydrolysis and Ca2+ occlusion.150,348 It is unclear whether SLN disrupts this 
process causing slippage of the Ca2+ back into the cytosol or whether it promotes the 
SERCA-mediated passive leak of Ca2+ from the lumen to the cytosol without the 
concurrent production of ATP.96,122,372,373 Recent studies proposed that salt-bridges 
between the N-terminus of SLN and the cytosolic portion of M4 in SERCA cause the 
uncoupling of ATP hydrolysis and Ca2+ transport through altering Ca2+-binding site II165 or 
interfering with TM sliding.164 However, the conclusions from those studies do not entirely 
account for the fact that the N-terminus of human SLN could not form salt-bridges quite 
like the rabbit or mouse sarcolipin sequences used in the studies, nor do they consider 
the 100% sequence conservation in the luminal tail of SLN among mammals. 
Furthermore, the preliminary INEPT data suggested that the N-terminus does not interact 
with SERCA, but that the luminal tail does. It should be noted that the study by Autry et al. 
indicated that the Glu-2 salt bridge to SERCA could be replaced by Glu-7, which is highly 
conserved and present in the human sequence.165 However, more studies are needed to 
elucidate how SLN uncouples Ca2+ transport and ATP hydrolysis in SERCA as well as if 
there are differences depending on the species-specific N-terminal sequences. Lastly, 
although SLN alters SERCA’s activity differently than PLN and there is no evidence yet 
that SLN has T, R, and B states like PLN, phosphorylation of SLN’s N-terminus does 
appear to reverse inhibition, indicating it does play a regulatory role similar to the 
cytoplasmic helix of PLN. It is likely that structural studies of pSLN will help to elucidate 
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both the role of the N-terminus and the mechanism of uncoupling. Overall, much remains 
to be understood about how SERCA’s activity is regulated by SLN.   
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Figure 1. Phosphorylation of SLN by CaMKII. The phosphorylation reaction was carried 
out overnight at 33 °C and detected using an anti-phosphothreonine antibody. Synthetic 
pSLN (syn pSLN) was included as a control for ensuring the antibody detected pSLN. PLN 
was also included as a control to ensure that the CaMKII was active. The remaining 
reactions contained SLN solubilized in different detergents. Without CaMKII, no 
phosphorylation was detected, but with CaMKII, phosphorylation was detected in the 
C12E8 reaction, and there is also a faint band for the reaction in DDM (n-dodecyl β-D-
maltoside). No phosphorylation was detected for the reactions in DPC or the two different 
concentrations of OG (n-octyl-β-D-glucoside). 
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Figure 2. ATP hydrolysis assays with pSLN. A) The raw data for the ATP hydrolysis assay 
when the ionophore A23187 is present. The data from the assays with and without 
ionophore were fit to the Hill equation to extract the B) KpCa and C) Vmax values.  
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Figure 3. ATP hydrolysis assays at various concentrations of Mg2+. The ATPase activity 
of SERCA was measured using the normal range of pCa values, but under several 
concentrations of MgCl2 as well. These data were fit to the Hill equation to obtain the Vmax 
and KpCa values for a range of Mg2+ concentrations including those near to what was used 
to crystallize the SLN and SERCA complex (3W5A and 4H1W at 40 mM158 and ~75 mM159 
[Mg2+], respectively). 
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Figure 4. Comparison of NCA spectrum for SLN alone to previously published data. The 
data from glycerol/low centrifuge speed preparation are presented here in black whereas 
the previously published data (including previously proposed assignments)145 are in green. 
These spectra do not overlay well suggesting that the data here represent a sample that 
has more conformational heterogeneity, which could be due to several factors related to 
the sample preparation. 
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Figure 5. Comparison of the DARR data for the SLN alone sample from this work (A) as 
well as the previously published data145 (B). The peaks corresponding to valines, 
isoleucines, and leucines overlay well, but there are differences in the number of peaks 
observed in this area of the spectra. For example, the spectrum in B has more peaks that 
were assigned to Glu-7, Phe-9, and Phe-12. However, the linewidths of the hydrophobic 
residues remain narrow (see associated table) indicating that the sample in (A) is not 
aggregated compared to (B). However, these spectra cannot be compared completely 
head-to-head as they were acquired using different mixing times (40 ms for A and 100 ms 
for B) and using different magnetic fields (600 MHz for A and 700 MHz for B), all of which 
can affect the parameters of the components being discussed. 
 
 
 
 
 
 
 
  
 
Linewidths Linewidths 
Leu CB-CA 125 Hz 106 Hz 
Ile CB-CA 121 Hz 137 Hz 
Val CB-CA 121 Hz 149 Hz 
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Figure 6. Comparison of all the NCA spectra for the samples prepared herein. The 
assignments based on the previously-published SLN alone sample145 are marked by x’s 
(also see Fig. 4). The SLN+E1AMPPCP SERCA and SLN+E2AMPPCP SERCA spectra 
are similar in appearance to the SLN alone spectrum (Top and Middle) indicating that 
they may all have conformational heterogeneity. Interestingly, there are shifts in some of 
the peaks (Top, Middle, and Bottom), which is congruent with the structure of SLN 
changing when it binds to different states of SERCA. However, these peaks cannot be 
assigned as the spectra are so different from the published assignments. 
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Figure 7. Comparison of the DARR data for the SLN alone sample with SLN+SERCA 
samples from this work. The peaks corresponding to the valines, isoleucines, and leucines 
overlay well, but the same peaks are missing the in the SLN+SERCA samples as the SLN 
alone sample compared to the previously published data145 (Fig. 5). However, the 
linewidths of the hydrophobic residues are similar indicating that none of the samples are 
aggregated. All the spectra were acquired with a 20 ms mixing time.   
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Figure 8. 1D MAS cross polarization spectra of SLN alone and SLN bound to SERCA in 
the E1-AMPPCP state. The signal intensity decreases from 2 °C to 25 °C for SLN by itself, 
which indicated that at 25 °C SLN has become more dynamic decreasing the efficiency of 
the cross-polarization. However, when SERCA (E1AMPPCP) is present, no such change 
in signal intensity is observed suggesting that even with Ca2+ and nucleotide present, SLN 
still binds to SERCA. This is not the ideal method to observe binding as other factors could 
be influencing the signal intensity. As such, other experiments should be completed to 
confirm that SLN is bound to E1-AMPPCP SERCA under our conditions.  
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Figure 9. Comparison of SLN alone ref-INEPT (black) to previously published ref-INEPT 
(green).145  The peaks corresponding to the N-terminus (I3 and M1) as well as the C-
terminus/luminal tail (Q30) overlay well. Note that the Y31 peaks do not overlay as the 
published spectra was acquired with a smaller spectral width causing these peaks to be 
folded in the spectrum.  
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Figure 10. Overlays of the ref-INEPT spectra of SLN alone (black) and bound to SERCA 
either in the E1- (red, Top) or E2-AMPPCP (blue, Bottom) states. The spectra were 
acquired at 25 °C. The mobile residues of both the N- and C-termini are observed when 
SLN is by itself. However, when SERCA is present, the peaks corresponding to the 
residues in the C-terminus/luminal tail, e.g. Y31 and Q30, decrease in intensity (there is 
no blue left for either of these peaks, and only a small red peak for Y31HE-CE). This 
indicates that they are less mobile, and thus, likely binding to SERCA. In both states, the 
residues of the N-terminus are still visible indicating that they remain mobile and not bound 
to SERCA. These data were plotted at the same noise level to account for the different 
amounts of SLN used in the samples using a MATLAB script kindly provided by Dr. Manu 
Subrahmanian.   
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Figure 11. Sequence alignment of SLN for human, mouse, and rabbit. Although the C-
terminus/luminal tail is perfectly conserved, the N-terminus is more variable.  
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Figure 12. PISEMA spectra for SLN bound to SERCA in the E2-AMPPCP state and then 
with Ca2+ added (E1-AMPPCP). With this sample, and all subsequent complex samples, 
the bicelle sample was taken out of the probe, CaCl2 was quickly added, and the sample 
was placed back into the instrument. Addition of Ca2+ clearly altered the appearance of 
the spectra, even though the tilt angle is similar between the two spectra, indicating that 
the Ca2+ is interacting with SERCA and affecting SLN. The free concentrations of ATP, 
Mg2+, Ca2+, and EGTA in these samples were calculated using the CHELATOR program374 
and are shown in the table below. Although EGTA and ATP have some affinity for Mg2+ 
and Ca2+, respectively, the Mg2+ is predominantly bound to ATP and the Ca2+ to EGTA. 
There is enough free [Ca2+] to bind to SERCA to form the E1-AMPPCP state.  
  
SLN+E2-
AMPPCP 
SLN+E1-
AMPPCP 
Total [ATP*]  2.0 mM 2.0 mM 
Free [ATP*] 0.3 mM 0.1 mM 
Total [Mg2+] 2.5 mM 2.5 mM 
Free [Mg2+] 0.8 mM 1.3 mM 
Total [Ca2+] 0 mM 4.0 mM 
Free [Ca2+] 0 mM 1.3 mM 
Total [EGTA] 2.0 mM 2.0 mM 
Free [EGTA] 2.0 mM 0.001 mM 
 
*The CHELATOR program uses ATP, but the dissociation constants of AMPPCP for Ca2+ 
and Mg2+ are similar to ATP,375 so this change should not dramatically affect the calculated 
free concentrations of these ions.   
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Figure 13. PISEMA spectra of SLN alone for the three labeling schemes (Bottom) 
compared to the uniformly-labeled sample (Top). The 15N-Leu sample (purple) had 4 
peaks as expected (Leu-16, Leu-21, Leu-24, and Leu-25), and the 15N-Ile sample (blue) 
had three peaks as expected (Ile-14, Ile-17, and Ile-20). The last sample, in which all 
residues except leucine, isoleucine, and valine are 15N-labeled, also matched well. Thus, 
the SLN from these purifications was used in studies with SERCA. 
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Figure 14. Comparison of selectively-labeled SLN bound to SERCA in the E2- and E1- 
AMPPCP states. (A) Overlaying the 15N-Leu SLN bound to the E2- and E1-AMPPCP 
states demonstrates that SLN’s structure does change. Initially, the sample was prepared 
as the E2AMPPCP state, but after that spectrum was acquired, 4 mM CaCl2 was added 
to promote the E1-AMPPCP state. Addition of CaCl2 changed the spectrum, further 
verifying that SLN is bound to SERCA, and that Ca2+ interacted with SERCA. Significantly, 
a new peak appeared upon addition of Ca2+. Based on a previous assignment147 and the 
periodicity of the PISA wheel, this peak is likely Leu-10.  (B) Comparison of the 15N-Ile 
SLN bound to the E2- and E1-AMPPCP states also shows slight changes upon the 
addition of Ca2+.  
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Figure 15. Estimated assignment of uniformly 15N-labeled SLN bound to SERCA in the 
E2- AMPPCP state and with 4 mM CaCl2 added.  Although the overall tilt and rotation 
angle is similar between the two states, the addition of CaCl2 caused the overall 
appearance and many peaks to change. Based on the selectively-labeled samples, the 
N-terminal end of the TM helix is more structured bound to SERCA in the E1-AMPPCP 
state compared to the E2-AMPPCP state. Changes in the peaks is especially apparent for 
the terminal residues that are outside of the wheel from ~110 to 125 ppm and 0.8 kHz.  
Additional labeling schemes could help to identify what residues these peaks correspond 
to.  
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Table 1. Estimated chemical shifts and dipolar couplings from the oriented SLN+SERCA 
samples. 
 
E1-AMPPCP 
  
E2-AMPPCP 
 
  
Chemical Shift 
(ppm) 
Dipolar 
Coupling 
(kHz)   
Chemical 
Shift (ppm) 
Dipolar 
Coupling 
(kHz) 
L10 100 4    
N11      
F12 88 2  91 2 
T13 81 4.2  86 3.6 
I14 104 3.6  105 3.6 
V15 96 1.9  96 1.9 
L16 80 2.8  81 2.9 
I17 87 4.3  89 4 
T18 101 2.7  102 2.6 
V19 91 1.9  92 1.9 
I20 81 3.3  82 3.3 
L21 97 4.2  98 4.2 
M22 100 2.2  101 2.1 
W23 81 2.9  81 2.6 
L24 84 3.7  84 3.9 
L25 105 3.4  106 3.5 
V26 86 2.3  86 2.3 
R27      
S28      
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Figure 16. Proposed model in which SLN acts as a wedge inhibiting the movement of 
SERCA’s TM helices. The topologies of M1 and M2 change significantly depending on 
whether Ca2+ is bound, and these changes are propagated to the cytoplasmic domains. 
SLN (red) binds to the groove formed by M2, M4, M6, and M9 (in yellow), thus it likely 
interferes with their movements, which may be the explanation for the decrease in 
SERCA’s apparent calcium affinity. Further experiments are needed to better understand 
the role of SLN’s terminal residues. (PDB IDs: 1T5S, 2C8K. Note that SLN’s position is 
merely approximated to illustrate how it could interfere with SERCA.)  
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Chapter 6 – Conclusions  
Biophysical Characterization of Interactions Between Two Membrane 
Proteins: SERCA and Sarcolipin 
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6.1 Conclusions  
 In summary, the work included in this thesis has focused on the biophysical 
characterization of membrane proteins. Chapter 2 illustrates the use of several biophysical 
methods including solution-state NMR spectroscopy to characterize the antimicrobial 
peptide, chionodracine (Cnd).376 The results demonstrate that Cnd is largely unstructured 
until it interacts with lipid membranes, at which point it becomes α-helical and forms pores, 
thereby fragmenting the bacterial membrane and killing the bacteria. The labeling via 
ethylation of cysteines as described in Chapter 3 can be utilized to study large, functional 
proteins that cannot be labeled though conventional methods. The utility of this site-
directed labeling method was illustrated in studies of SERCA conformational transitions.377 
In Chapter 4, water-edited O-ssNMR experiments were used to examine the residue-
specific hydration of SLN within a lipid bilayer system (bicelles).71 This method may be 
expanded to other systems to study the hydration of membrane proteins and may even 
help simplify the spectra for the structural determination of larger proteins. Finally, the 
OssNMR and preliminary MAS characterization of the SERCA+SLN complex discussed 
in Chapter 5 indicate that SLN does not appear to dissociate from SERCA when Ca2+ 
binds, but may form a wedge inhibiting conformational changes required for Ca2+ transport 
by SERCA. One of the main challenges in studying the SERCA+SLN complex by ssNMR 
is that we currently do not have the tools to isotopically label SERCA like we do for SLN. 
To this end, the methods described in Chapters 3 and 4 could be applied to further 
investigate the SERCA+SLN complex as well as other peptide regulators of SERCA. For 
example, the ethyl labeling of SERCA could enable following of changes in SERCA’s 
cytoplasmic domains when SLN is bound compared to when SERCA is free. Given that 
SLN affects coupling between ATP hydrolysis and Ca2+ transport, it seems likely that 
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structural changes from SLN binding to the TM domain would propagate to the 
cytoplasmic domains of SERCA resulting in a different signature of the ethyl chemical 
shifts (preliminary data from a previous student supports this370). Moreover, these changes 
would also probably be different than the peptide regulators of SERCA that do not cause 
uncoupling. Further development of ssNMR methods will aid greatly in elucidating the 
molecular mechanism of regulation of SERCA by SLN and other peptides.  
 Discoveries are still being made about SERCA and its regulation, which is exciting 
especially as SERCA is one of the most well-studied membrane proteins. Within the last 
several years, both novel post-translational modifications for SLN and PLN as well as 
several new regulators of SERCA have been found. SLN from rabbit and pig was found 
to be both S-palmitoylated and S-oleoylated at Cys-9, which appears to affect ATP 
hydrolysis by SERCA.378 While both rabbit and pig SLN have cysteines at position 9, in 
humans this residue is replaced by phenylalanine, so human SLN would not be modified 
in this manner. Modification of PLN by N-acetylglucosamine (O-GlcNAc) was also recently 
reported with the site of the modification likely being Ser-16 (it is not yet conclusive that 
the site of glycosylation is Ser-16 rather than Thr-17)379 (Fig. 1A and 1B). Increased O-
GlcNAcylation is linked to hyperglycemia, one of the contributing factors to diabetic 
cardiomyopathy.380 Given the importance of the SERCA+PLN complex to proper Ca2+ 
homeostasis and ventricular function,112,248,381-383 it will be crucial to understand how the 
O-GlcNAcylation of PLN contributes to ventricular dysfunction in diabetic cardiomyopathy. 
The modification of PLN by O-GlcNAc undoubtedly interferes with phosphorylation at both 
possible phosphorylation sites (PLN can be phosphorylated by PKA at Ser-16 and CaMKII 
at Thr-17) resulting in glycosylation interfering with the reversal of PLN’s inhibition of 
SERCA. As such, we began to study this system and performed in vitro assays to modify 
  155 
PLN with O-GlcNAc for the first time. Figure 1C shows the preliminary data indicating that 
the cytoplasmic domain of PLN is indeed O-GlcNAcylated by O-linked β-N-
acetylglucosamine transferase (OGT). Although this was only clear for the cytoplasmic 
domain, that is likely because the cytoplasmic domain is soluble, so no detergents were 
needed. The wild-type (WT) and monomeric (AFA) versions of PLN require detergent, 
which can interfere with the activity of the enzymes in the assay as well as the 
quantification by the assay reagents. In fact, one of the controls indicated that C12E8 
decreased the activity of the coupling phosphatase. Thus, more assays are needed to fully 
understand whether AFA and WT PLN are glycosylated or if detergent interfered with this 
assay. However, the information gained from studies with O-GlcNAc-PLN would be highly 
useful as the effects of O-GlcNAcylation are generally not well understood at the molecular 
level:380,384,385 does O-GlcNAcylation merely prevent phosphorylation?386 By PKA and 
CaMKII? Or does it have its own effect on PLN’s structure and thus SERCA’s activity as 
structural changes have been observed for other proteins?386 It will be very interesting to 
carry out further characterization of the O-GlcNAc-PLN+SERCA complex as well as the 
palmitoylation and oleoylation of SLN, which may shed light on how different species have 
evolved to regulate SERCA’s activity according to their own needs.  
 Also fascinating is the recent discovery of several new regulators of SERCA: 
myoregulin (MLN),104 DWORF,105 the sarcolambans (SCL) in Drosophila,106 endoregulin 
(ELN) and another-regulin (ALN),107 as well as small Ankyrin 1.108 Thus, regulating SERCA 
through peptides seems to be a conserved mechanism for controlling Ca2+ dynamics.106,107 
These studies have already revealed functional differences. MLN, ELN, ALN, and likely 
the SCLs all inhibit SERCA similar to SLN and PLN,104,106,107 whereas DWORF counteracts 
the effects of inhibitory peptides.105 Furthermore, while most of these peptides are 
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expressed in either cardiac and/or skeletal muscle,104,106,107 ALN is also expressed in other 
tissues including the epidermal epithelium, salivary gland, and brown fat.107 ELN was 
expressed almost entirely in non-muscle tissue where it would regulate SERCA3, so 
perhaps regulation is isoform-specific.107 Interestingly, these peptides display a high 
conservation of several amino acids within the transmembrane region, but exhibit greater 
variability in their terminal regions.107 It will be curious to see if these different termini have 
disparate effects on SERCA’s activity and/or whether they relate to regulation of the 
peptide (e.g. through reversal of inhibition via phosphorylation like PLN and SLN). Further 
characterization of these peptides with SERCA will undoubtedly help elucidate the 
mechanism of regulation and its variations. In turn, this will aid in the design of new 
therapeutics to help modulate Ca2+ cycling through SERCA in associated diseases such 
as dilated cardiomyopathy, Brody’s disease, and obesity.  
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Figure 1. O-GlcNAcylation of PLN by O-linked β-N-acetylglucosamine transferase (OGT). 
(A) NMR structure of PLN (PDB ID:2KB7) with the position of Ser-16 indicated. (B) O-
GlcNAcylation and O-phosphorylation of serine. (C) Data indicating that the cytoplasmic 
domain of PLN can be O-GlcNAcylated. Assay was performed using a kit from R&D 
Systems (Catalog #EA001) that measures the activity of glycosyltransferases via a 
coupled-enzyme assay that quantifies inorganic phosphate via malachite green. 
Comparing wells 1 and 2 indicated that some WT PLN may have been glycosylated by 
OGT, whereas glycosylation of AFA is not evident (wells 3 and 4). The cytoplasmic domain 
of PLN (residues 1-19) showed the clearest evidence of glycosylation (well 5). Wells 7-9 
were controls to determine whether the detergent, C12E8, affected the assay. Well 7 
included all of the assay components except PLN to ensure the detergent did not introduce 
a significant background. Wells 8 and 9 compared the effects of C12E8 on the coupled 
enzyme (coupling phosphatase 1). They contained the phosphatase and its substrate, 
UDP, but well 8 included C12E8, whereas well 9 was detergent free. The phosphatase was 
less active in the presence of C12E8. 
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